MCID: TNG009
MIFTS: 44

Tongue Squamous Cell Carcinoma

Categories: Cancer diseases, Gastrointestinal diseases, Oral diseases

Aliases & Classifications for Tongue Squamous Cell Carcinoma

MalaCards integrated aliases for Tongue Squamous Cell Carcinoma:

Name: Tongue Squamous Cell Carcinoma 12 15 17
Squamous Cell Carcinoma of Tongue 71

Classifications:



External Ids:

Disease Ontology 12 DOID:0050865
NCIt 49 C4648
SNOMED-CT 67 276952000
UMLS 71 C0349566

Summaries for Tongue Squamous Cell Carcinoma

Disease Ontology : 12 A head and neck squamous cell carcinoma that is located in the tongue.

MalaCards based summary : Tongue Squamous Cell Carcinoma, also known as squamous cell carcinoma of tongue, is related to tongue carcinoma and oral cavity cancer. An important gene associated with Tongue Squamous Cell Carcinoma is MIR21 (MicroRNA 21), and among its related pathways/superpathways are MicroRNAs in cancer and LncRNA-mediated mechanisms of therapeutic resistance. The drugs Cetuximab and Antineoplastic Agents, Immunological have been mentioned in the context of this disorder. Affiliated tissues include tongue, lymph node and endothelial.

Related Diseases for Tongue Squamous Cell Carcinoma

Diseases related to Tongue Squamous Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 118, show less)
# Related Disease Score Top Affiliating Genes
1 tongue carcinoma 32.1 MIR21 MIR195 MIR139 MALAT1
2 oral cavity cancer 31.0 MIR483 MIR21 MIR195 MIR139
3 oral squamous cell carcinoma 30.9 UCA1 MIR21 MIR195 MIR139 MIR133B MEG3
4 thyroid cancer, nonmedullary, 1 30.7 MIR222 MEG3 MALAT1 HOTTIP
5 squamous cell carcinoma, head and neck 30.5 MIR483 MIR21 MIR195 MIR139 CYTOR
6 renal cell carcinoma, nonpapillary 30.3 UCA1 MIR21 MIR195 MIR139 MALAT1 CYTOR
7 esophageal cancer 29.9 UCA1 NKILA MIR483 MIR21 MIR139 MEG3
8 lung cancer susceptibility 3 29.6 MIR483 MIR21 MIR139 MEG3 MALAT1 CYTOR
9 nasopharyngeal carcinoma 29.5 NKILA MIR21 MIR139 MEG3 MALAT1 AFAP1-AS1
10 squamous cell carcinoma 11.3
11 oral cancer 10.8
12 polymyositis 10.7 MIR222 MIR21
13 small cell cancer of the lung 10.5 MIR21 MALAT1 HOTTIP
14 vulva squamous cell carcinoma 10.5 MEG3 MALAT1
15 intestinal benign neoplasm 10.5 MIR483 MIR21 MIR139
16 endocrine organ benign neoplasm 10.5 MIR483 MIR21 MIR139
17 glioma susceptibility 1 10.5 MIR222 MIR21 MEG3 MALAT1 CYTOR
18 gastrointestinal system benign neoplasm 10.5 MIR483 MIR21 MIR139
19 lymphatic system cancer 10.4 MIR483 MIR222 MIR21 MIR139
20 lymphatic system disease 10.4 MIR483 MIR222 MIR21 MIR139
21 ovary epithelial cancer 10.4 MIR483 MIR21 MIR139
22 malignant glioma 10.4 MEG3 MALAT1 HOTTIP CYTOR
23 malignant ovarian surface epithelial-stromal neoplasm 10.4 MIR483 MIR21 MIR139
24 intestinal disease 10.4 MIR483 MIR222 MIR21 MIR139
25 osteogenic sarcoma 10.4 UCA1 MEG3 MALAT1 HOTTIP
26 rectum cancer 10.4 MIR483 MIR21 MIR139
27 nervous system disease 10.4 MIR483 MIR222 MIR21 MIR139
28 bile duct disease 10.4 MIR483 MIR222 MIR139
29 nasopharyngeal disease 10.4 MIR483 MIR21 MIR139
30 cervix disease 10.4 MIR483 MIR21 MIR195 MIR139
31 connective tissue cancer 10.4 MIR483 MIR21 MIR195 MIR139
32 myeloma, multiple 10.4 UCA1 MIR483 MIR21 MEG3 MALAT1
33 biliary tract disease 10.4 MIR483 MIR222 MIR139
34 pharynx cancer 10.4 MIR483 MIR21 MIR139
35 pancreas disease 10.4 MIR483 MIR21 MIR195 MIR139
36 miyoshi muscular dystrophy 1 10.4 MIR222 MIR21
37 colonic disease 10.4 MIR483 MIR21 MIR195 MIR139
38 uterine anomalies 10.4 MIR483 MIR21 MIR195 MIR139
39 cell type benign neoplasm 10.4 MIR483 MIR21 MIR139
40 urinary system disease 10.4 MIR483 MIR21 MIR195 MIR139
41 endocrine system disease 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
42 male reproductive organ cancer 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
43 male reproductive system disease 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
44 reproductive system disease 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
45 large intestine cancer 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
46 endocrine gland cancer 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
47 respiratory system cancer 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
48 female reproductive system disease 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
49 esophageal disease 10.4 MIR483 MIR21 MIR139
50 thoracic cancer 10.4 MIR483 MIR222 MIR21 MIR195 MIR139
51 squamous cell papilloma 10.3
52 papilloma 10.3
53 b-cell lymphoma 10.3
54 respiratory system disease 10.3 MIR483 MIR222 MIR21 MIR195 MIR139
55 gastrointestinal system disease 10.3 MIR483 MIR222 MIR21 MIR195 MIR139
56 overnutrition 10.3 MIR483 MIR222 MIR21
57 clear cell renal cell carcinoma 10.3 MIR21 MEG3 MALAT1 CYTOR
58 upper respiratory tract disease 10.3 MIR483 MIR21 MIR139
59 glioma 10.3 UCA1 MIR222 MIR21 MEG3 MALAT1 HOTTIP
60 gastrointestinal system cancer 10.3 MIR483 MIR222 MIR21 MIR195 MIR139 MALAT1
61 central nervous system cancer 10.3 MIR222 MIR21 MIR139
62 leukoplakia 10.3
63 leukemia, acute myeloid 10.2 UCA1 MIR483 MIR222 MIR21 MIR195 MEG3
64 prostate disease 10.2 MIR483 MIR222 MIR21 MIR195 MIR139 MEG3
65 cervical cancer 10.2
66 alcohol use disorder 10.2
67 oropharynx cancer 10.2
68 rapidly involuting congenital hemangioma 10.2
69 tongue disease 10.2 UCA1 MIR483 MIR21 MIR195 MIR139 LINC00673
70 microvascular complications of diabetes 3 10.2 MIR21 MALAT1
71 melanoma 10.1 UCA1 NKILA MIR222 MIR139 MEG3 MALAT1
72 paragangliomas 6 10.1
73 leiomyoma 10.1
74 pulmonary embolism 10.1
75 hypereosinophilic syndrome 10.1
76 oral leukoplakia 10.1
77 hypoxia 10.1
78 connective tissue disease 10.0 MIR483 MIR222 MIR21 MIR139
79 cholangiocarcinoma 10.0 UCA1 MIR21 MALAT1 AFAP1-AS1
80 polykaryocytosis inducer 10.0
81 dowling-degos disease 1 10.0
82 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
83 mucositis 10.0
84 covid-19 10.0
85 rasopathy 10.0
86 keratosis 10.0
87 myoma 10.0
88 cervix carcinoma 10.0
89 severe acute respiratory syndrome 10.0
90 mesenchymal cell neoplasm 10.0
91 skin carcinoma 10.0
92 lynch syndrome 10.0
93 lung squamous cell carcinoma 10.0
94 syphilis 10.0
95 neuromuscular disease 10.0
96 severe combined immunodeficiency 10.0
97 tertiary syphilis 10.0
98 periodontitis 10.0
99 neurofibromatosis 10.0
100 hypoglycemia 10.0
101 47,xyy 10.0
102 cytokine deficiency 10.0
103 tetraploidy 10.0
104 inflammatory myopathy with abundant macrophages 10.0
105 pre-descemet corneal dystrophy 10.0
106 argyria 10.0
107 thyroid carcinoma 10.0
108 esophagus squamous cell carcinoma 9.9 MEG3 AFAP1-AS1
109 thyroid gland cancer 9.9 UCA1 MIR222 MALAT1 AFAP1-AS1
110 gallbladder cancer 9.9 UCA1 MEG3 MALAT1 CYTOR AFAP1-AS1
111 bladder cancer 9.8 UCA1 MIR222 MIR21 MIR195 MIR139 MIR133B
112 pancreatic ductal adenocarcinoma 9.7 UCA1 MIR483 MIR222 MIR21 MALAT1 LINC00673
113 gastric cancer 9.5 UCA1 MIR222 MIR21 MEG3 MALAT1 LINC00673
114 ovarian cancer 9.3 UCA1 MIR483 MIR222 MIR21 MIR195 MIR139
115 pancreatic cancer 9.2 UCA1 MIR483 MIR222 MIR21 MIR195 MIR139
116 hepatocellular carcinoma 9.1 UCA1 PCBP2-OT1 NKILA MIR483 MIR222 MIR21
117 colorectal cancer 8.7 UCA1 MIR483 MIR222 MIR21 MIR195 MIR139
118 lung cancer 8.6 UCA1 PCBP2-OT1 NKILA MIR483 MIR222 MIR21

Graphical network of the top 20 diseases related to Tongue Squamous Cell Carcinoma:



Diseases related to Tongue Squamous Cell Carcinoma

Symptoms & Phenotypes for Tongue Squamous Cell Carcinoma

Drugs & Therapeutics for Tongue Squamous Cell Carcinoma

Drugs for Tongue Squamous Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 9, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cetuximab Approved Phase 1, Phase 2 205923-56-4 56842117 2333
2 Antineoplastic Agents, Immunological Phase 1, Phase 2
3
Ribavirin Approved 36791-04-5 37542
4
Luteolin Experimental Early Phase 1 491-70-3 5280445
5 Anesthetics
6 Hemostatics
7 Antiviral Agents
8 Antimetabolites
9 Anti-Infective Agents

Interventional clinical trials:

(showing 6, show less)
# Name Status NCT ID Phase Drugs
1 CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment Followed by 6 Weeks of Cetuximab+RT Post Surgery in Locally Advanced Squamous Cell Carcinoma of the Tongue ; A NEW PARADIGM OF TREATMENT Unknown status NCT01760811 Phase 1, Phase 2 Erbitux,merck serono
2 Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer Recruiting NCT03224000 Phase 2
3 Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line: In Vitro Study Unknown status NCT03288298 Early Phase 1 luteolin;nano-luteolin
4 Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva Unknown status NCT00426062
5 Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma (Randomize Noninferiority Clinical Trial) Active, not recruiting NCT03440151
6 A Pilot Study to Assess the Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma Active, not recruiting NCT01268579 ribavirin

Search NIH Clinical Center for Tongue Squamous Cell Carcinoma

Genetic Tests for Tongue Squamous Cell Carcinoma

Anatomical Context for Tongue Squamous Cell Carcinoma

The Foundational Model of Anatomy Ontology organs/tissues related to Tongue Squamous Cell Carcinoma:

19
Tongue

MalaCards organs/tissues related to Tongue Squamous Cell Carcinoma:

40
Tongue, Lymph Node, Endothelial, T Cells, Tonsil, Skeletal Muscle, Bone

Publications for Tongue Squamous Cell Carcinoma

Articles related to Tongue Squamous Cell Carcinoma:

(showing 1220, show less)
# Title Authors PMID Year
1
MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. 46 61
19487542 2009
2
Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. 61 46
18464261 2008
3
MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. 46
19509158 2009
4
AEG-1 promotes angiogenesis and may be a novel treatment target for tongue squamous cell carcinoma. 61
32031319 2020
5
Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma. 61
31411752 2020
6
Tumor-Infiltrating CD1a+ DCs and CD8+/FoxP3+ Ratios Served as Predictors for Clinical Outcomes in Tongue Squamous Cell Carcinoma Patients. 61
31606786 2020
7
Tumor histologic grade as a risk factor for neck recurrence in patients with T1-2N0 early tongue cancer. 61
32330684 2020
8
Level IV neck dissection as an elective treatment for oral tongue carcinoma-a systematic review and meta-analysis. 61
32540318 2020
9
Upregulation of long noncoding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma. 61
32531865 2020
10
High detection sensitivity and reliable morphological correlation of PET with a silicon photomultiplier for primary tongue squamous cell carcinoma. 61
32564300 2020
11
High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma. 61
32307911 2020
12
[Effects of RAB1A on the proliferation, invasion, and metastasis of tongue squamous cell carcinoma cells]. 61
32573129 2020
13
Benzo[a]pyrene promotes progression in tongue squamous cell carcinoma. 61
32557985 2020
14
Squamous Cell Carcinoma of the Oral Tongue in Young Patients: Outcomes and Implications for Treatment. 61
32523275 2020
15
CA9 transcriptional expression determines prognosis and tumour grade in tongue squamous cell carcinoma patients. 61
32299152 2020
16
Increasing incidence and improving survival of oral tongue squamous cell carcinoma. 61
32398670 2020
17
LncRNA-MALAT1 is a promising biomarker for prognostic evaluation of tongue squamous cell carcinoma. 61
32383096 2020
18
Anatomically-based transoral surgical approach to early-stage oral tongue squamous cell carcinoma. 61
32003091 2020
19
ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells. 61
32097729 2020
20
Persistent and Chronic Postoperative Opioid Use in a Cohort of Patients with Oral Tongue Squamous Cell Carcinoma. 61
31609416 2020
21
Exome sequencing identifies new somatic alterations and mutation patterns of tongue squamous cell carcinoma in a Chinese population. 61
32432340 2020
22
SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma. 61
32366599 2020
23
Circular RNA_0001742 has potential to predict advanced tumor stage and poor survival profiles in tongue squamous cell carcinoma management. 61
32463532 2020
24
Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining. 61
32451767 2020
25
Knockdown of ectodysplasin-A receptor-associated adaptor protein exerts a tumor-suppressive effect in tongue squamous cell carcinoma cells. 61
32266031 2020
26
Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8+ T cells and regulatory T cell-dominance, compared to skin SCC. 61
32204917 2020
27
Modified in-continuity resection is advantageous for prognosis and as a new surgical strategy for management of oral tongue cancer. 61
32102766 2020
28
Comparison of Clinical Results and Quality of Life in Tongue Cancer Patients Undergoing Submental Island Flap and Radial Forearm Free Flap Reconstruction. 61
32504562 2020
29
Assessment of TLR4 and TLR9 signaling and correlation with human papillomavirus status and histopathologic parameters in oral tongue squamous cell carcinoma. 61
32173390 2020
30
Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. 61
31219623 2020
31
Asparaginase induces selective dose- and time-dependent cytotoxicity, apoptosis, and reduction of NFκB expression in oral cancer cells. 61
31943292 2020
32
Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling. 61
32325539 2020
33
SEMA3A Exon 9 Expression Is a Potential Prognostic Marker of Unfavorable Recurrence-Free Survival in Patients with Tongue Squamous Cell Carcinoma. 61
32074456 2020
34
Long non‑coding RNA PRNCR1 exerts oncogenic effects in tongue squamous cell carcinoma in vitro and in vivo by sponging microRNA‑944 and thereby increasing HOXB5 expression. 61
32319550 2020
35
[Effect of miR-204-5p on the proliferation, migration, and invasion on tongue squamous cell carcinoma SCC25 cells by targeting bromodomain-containing protein 4]. 61
32314893 2020
36
Knockdown of long non-coding RNA prostate cancer-associated transcript 1 inhibits the proliferation and metastasis of tongue squamous cell carcinoma cells by upregulating p21. 61
32218838 2020
37
Early tongue carcinomas (clinical stage I and II): echo-guided three-dimensional diode laser mini-invasive surgery with evaluation of histological prognostic parameters. A study of 85 cases with prolonged follow-up. 61
31834561 2020
38
The promise of immunotherapy in the treatment of young adults with oral tongue cancer. 61
32337355 2020
39
Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition. 61
31965456 2020
40
Podoplanin is an efficient predictor of neck lymph node metastasis in tongue squamous cell carcinoma with low tumor budding grade. 61
32218810 2020
41
Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B. 61
32310826 2020
42
Circular RNA expression profiling identifies specific circular RNAs in tongue squamous cell carcinoma. 61
32319610 2020
43
[Effects of farnesyltransferase silencing on the migration and invasion of tongue squamous cell carcinoma]. 61
32314892 2020
44
YY1-mediated PTEN dephosphorylation antagonizes IR-induced DNA repair contributing to tongue squamous cell carcinoma radiosensitization. 61
32334006 2020
45
Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance. 61
32300648 2020
46
Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma. 61
32339054 2020
47
Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival. 61
32281236 2020
48
Comparison of supervised machine learning classification techniques in prediction of locoregional recurrences in early oral tongue cancer. 61
31923822 2020
49
Prediction of postoperative lower respiratory tract infections in tongue cancer patients based on pretreatment swallowing function. 61
31886583 2020
50
Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence. 61
30767115 2020
51
Analyzing the factors that influence occult metastasis in oral tongue cancer. 61
32364349 2020
52
miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review. 61
31884798 2020
53
Effects of flavonoids on tongue squamous cell carcinoma. 61
31758641 2020
54
Significance of depth of invasion determined by MRI in cT1N0 tongue squamous cell carcinoma. 61
32170092 2020
55
Immunohistochemical expression of TFIIH and XPF in oral tongue squamous cell carcinoma. 61
31828418 2020
56
NIT2 overexpression predicts poor prognosis in tongue squamous cell carcinoma patients. 61
31925645 2020
57
Long non-coding RNA LINC00152 acts as a sponge of miRNA-193b-3p to promote tongue squamous cell carcinoma progression. 61
32194700 2020
58
SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression. 61
32089063 2020
59
The role of MRI-derived depth of invasion in staging oral tongue squamous cell carcinoma: inter-reader and radiological-pathological agreement. 61
31319692 2020
60
Usefulness of contrast-enhanced CT in the evaluation of depth of invasion in oral tongue squamous cell carcinoma: comparison with MRI. 61
32086730 2020
61
Bioinformatic screening and experimental analysis identify SFRP1 as a prognostic biomarker for tongue squamous cell carcinomas. 61
31734541 2020
62
Clinicopathological and prognostic significance of PD-1/PD-L1 axis expression in patients with tongue squamous cell carcinoma. 61
32030768 2020
63
Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma. 61
31633227 2020
64
Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis. 61
31769164 2020
65
[Expression and significance of microRNA-125b in tongue squamous cell carcinoma]. 61
32037760 2020
66
microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway. 61
31706018 2020
67
Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma. 61
32090103 2020
68
MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1. 61
32190006 2020
69
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma. 61
31937294 2020
70
Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes. 61
32250288 2020
71
TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. 61
32390763 2020
72
Progress in the study of long noncoding RNA in tongue squamous cell carcinoma. 61
31611036 2020
73
Myocyte-specific enhancer factor 2D promotes tumorigenesis and progression in tongue squamous cell carcinoma. 61
32509064 2020
74
Significance of SUV Max for Predicting Occult Lymph Node Metastasis and Prognosis in Early-Stage Tongue Squamous Cell Carcinoma. 61
32318108 2020
75
Lingual Lymph Node Metastasis in cT1-2N0 Tongue Squamous Cell Carcinoma: Is It an Indicator for Elective Neck Dissection. 61
32318349 2020
76
Tumor depth of invasion versus tumor thickness in guiding regional nodal treatment in early oral tongue squamous cell carcinoma. 61
31606422 2020
77
LncRNA CASC9 Affects Cell Proliferation, Migration, and Invasion of Tongue Squamous cell Carcinoma via Regulating miR-423-5p/SOX12 Axes. 61
32021442 2020
78
Significance of PET-CT for Detecting Occult Lymph Node Metastasis and Affecting Prognosis in Early-Stage Tongue Squamous Cell Carcinoma. 61
32328452 2020
79
Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma. 61
32308804 2020
80
A rare cause of small bowel perforation: A metastatic lesion from squamous cell carcinoma of the tongue. 61
32155586 2020
81
Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma. 61
31789398 2020
82
Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway. 61
31910357 2020
83
First case report of tongue squamous cell carcinoma in a neurofibromatosis type 1 patient and review of pathogenesis of carcinoma in neurofibromatosis type 1. 61
32031137 2020
84
Use of Purastat, a novel haemostatic matrix based on self-assembling peptides in the prevention of nasopharyngeal adhesion formation. 61
32422584 2020
85
Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells. 61
31765243 2020
86
Expression of RAD51 and Its Clinical Impact in Oral Squamous Cell Carcinoma. 61
32190537 2020
87
Inhibitory effect of the Notch pathway-inhibitor DAPT on invasion and metastasis of tongue cancer via lncRNA-KAT14 regulation. 61
31957832 2020
88
Prostaglandin E2 receptor EP4 regulates cell migration through Orai1. 61
31755615 2020
89
LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis. 61
31957833 2020
90
Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection. 61
32219070 2020
91
Inhibition of tropomyosine receptor kinase B on the migration of human Schwann cell and dispersion of oral tongue squamous cell carcinoma in vitro. 61
31497919 2019
92
Transcripto-based network analysis reveals a model of gene activation in tongue squamous cell carcinomas. 61
31589000 2019
93
Correction to: Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly. 61
31884950 2019
94
Circ_0001742 promotes tongue squamous cell carcinoma progression via miR-431-5p/ATF3 axis. 61
31841185 2019
95
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis. 61
31788070 2019
96
MRI evaluation of involvement of parotid and submandibular glands by tongue squamous cell carcinoma. 61
31901631 2019
97
Prognostic Value of a Family History of Oral Tongue Squamous Cell Carcinoma: A Matched-Pair Study. 61
31821562 2019
98
Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly. 61
31830929 2019
99
Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines. 61
31638167 2019
100
In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines. 61
31788102 2019
101
BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma. 61
31600692 2019
102
miR-611 promotes the proliferation, migration and invasion of tongue squamous cell carcinoma cells by targeting FOXN3. 61
31419344 2019
103
MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition. 61
31214736 2019
104
MicroRNA-21-5p targeting PDCD4 suppresses apoptosis via regulating the PI3K/AKT/FOXO1 signaling pathway in tongue squamous cell carcinoma. 61
31602231 2019
105
Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma. 61
31707626 2019
106
Value of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue. 61
30861130 2019
107
Hypermethylation of DcR1, DcR2, DR4, DR5 gene promoters and clinical significance in tongue carcinoma. 61
31399243 2019
108
"Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early-stage tongue squamous cell carcinoma". 61
31749213 2019
109
Cancer-associated fibroblasts in the tumor microenvironment of tongue carcinoma is a heterogeneous cell population. 61
31604589 2019
110
The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers-In Vitro Studies. 61
31766723 2019
111
Prognostic value of blood and lymphatic vessel markers in tongue cancer: A systematic review. 61
31495050 2019
112
Satisfactory short-term outcome after anlotinib and docetaxel chemotherapy in tongue cancer with N3 cervical lymph node metastasis: A case report. 61
31624610 2019
113
LncRNA CACS15 regulates tongue squamous cell carcinoma cell behaviors and predicts survival. 61
31665008 2019
114
Distant metastases in newly diagnosed tongue squamous cell carcinoma. 61
31206925 2019
115
Differences in gene expression between high-grade dysplasia and invasive HPV+ and HPV- tonsillar and base of tongue cancer. 61
31454186 2019
116
Heavy-ion beam irradiation inhibits invasion of tongue squamous cell carcinoma Tca8113 cells. 61
31516609 2019
117
[Research progress in the methods for evaluating depth of invasion of tongue squamous cell carcinoma]. 61
31607011 2019
118
LncRNA THOR promotes tongue squamous cell carcinomas by stabilizing IGF2BP1 downstream targets. 61
31220513 2019
119
Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer. 61
31290758 2019
120
Prevalence of human papilloma virus in oropharyngeal, tongue and lip squamous cell carcinoma: an experience from the Egyptian National Cancer Institute. 61
30867228 2019
121
Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool. 61
31422502 2019
122
The HSP90/Akt pathway may mediate artemether-induced apoptosis of Cal27 cells. 61
31376209 2019
123
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks. 61
31717887 2019
124
Analysis of Treg/Th17 cells in patients with tongue squamous cell carcinoma. 61
31452709 2019
125
Gene regulation analysis of the effects of evodiamine on tongue squamous cell carcinoma. 61
31081147 2019
126
Survival of oral tongue squamous cell carcinoma in young adults. 61
30985036 2019
127
MicroRNA-548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein 1. 61
31452716 2019
128
The use of carbon nanoparticles to track occult lingual lymph nodes in early-stage tongue squamous cell carcinoma. 61
30876796 2019
129
Using weighted gene co-expression network analysis to identify key modules and hub genes in tongue squamous cell carcinoma. 61
31517839 2019
130
Appraising Oncogenic Long Noncoding RNAs as Novel Biomarkers for Oral Tongue Squamous Cell Carcinoma: a Meta-Analysis. 61
31532111 2019
131
Oral tongue squamous cell carcinoma survival as stratified by age and sex: A surveillance, epidemiology, and end results analysis. 61
30575045 2019
132
Macrophage CCL22 expression in the tumor microenvironment and implications for survival in patients with squamous cell carcinoma of the tongue. 61
31134686 2019
133
Long non-coding RNA myocardial infarction associated transcript promotes epithelial-mesenchymal transition and is an independent risk factor for poor prognosis of tongue squamous cell carcinoma. 61
31166624 2019
134
The Mammalian Target of Rapamycin-70-kDa Ribosomal Protein S6 Kinase Axis Inhibits the Biological Function of Tongue Squamous Cell Carcinoma. 61
30339792 2019
135
Meta-analysis on risk factors of squamous cell carcinoma of the tongue in young adults. 61
31942130 2019
136
Cancer associated fibroblasts are distinguishable from peri-tumor fibroblasts by biological characteristics in TSCC. 61
31404347 2019
137
Oral squamous cell carcinoma of tongue: Histological risk assessment. A pilot study. 61
31422411 2019
138
Long noncoding RNA LINC00961 inhibited cell proliferation and invasion through regulating the Wnt/β-catenin signaling pathway in tongue squamous cell carcinoma. 61
30854692 2019
139
Prognostic Value of Cervical Nodal Necrosis Observed in Preoperative CT and MRI of Patients With Tongue Squamous Cell Carcinoma and Cervical Node Metastases: A Retrospective Study. 61
31039018 2019
140
[Biological effect of nicotine on Cal27 cell line in patients with tongue squamous cell carcinoma]. 61
31792475 2019
141
Systemic Air Embolism Following Computed Tomography-Guided Lung Biopsy. 61
31632862 2019
142
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. 61
31391008 2019
143
Establishment of syngeneic murine model for oral cancer therapy. 61
31345390 2019
144
Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model. 61
31171582 2019
145
The in vitro and in vivo antitumor effects of Dracaena cinnabari resin extract on oral cancer. 61
31176147 2019
146
The role of the T-N tract in advanced stage tongue cancer. 61
30942940 2019
147
Evaluation of early oral cavity cancer treatment quality at a single institution. 61
30408196 2019
148
Non-curative treatment of patients with oral tongue squamous-cell carcinoma. 61
31069467 2019
149
Association of SP1 rs1353058818 and STAT3 rs1053004 gene polymorphisms with human tongue squamous cell carcinoma. 61
31270251 2019
150
KRAS mutations in tongue squamous cell carcinoma. 61
31066593 2019
151
Validation of the International Tumor Budding Consensus Conference (2016) recommendations in oral tongue squamous cell carcinoma. 61
30927486 2019
152
Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma. 61
30972812 2019
153
High expression of FMNL3 associates with cancer cell migration, invasion, and unfavorable prognosis in tongue squamous cell carcinoma. 61
30955218 2019
154
Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma. 61
31324174 2019
155
Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarray. 61
31193592 2019
156
Long noncoding RNA FALEC inhibits proliferation and metastasis of tongue squamous cell carcinoma by epigenetically silencing ECM1 through EZH2. 61
31335317 2019
157
The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model. 61
31358054 2019
158
Suppression of the long non-coding RNA MALAT-1 impairs the growth and migration of human tongue squamous cell carcinoma SCC4 cells. 61
31360193 2019
159
R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling. 61
31097406 2019
160
Retraction Note: Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway. 61
31153369 2019
161
Outcomes after up-front surgery and metronomic neoadjuvant chemotherapy with S-1 or UFT for early tongue squamous cell carcinoma. 61
30317400 2019
162
Understanding the role of the R-spondin 2-LGR4 system in tongue squamous cell carcinoma progression. 61
31122842 2019
163
Deep convolutional neural networks for tongue squamous cell carcinoma classification using Raman spectroscopy. 61
31082525 2019
164
Importance of tumor budding grade as independent prognostic factor for early tongue squamous cell carcinoma. 61
30633412 2019
165
Early onset oral tongue squamous cell carcinoma: Associated factors and patient outcomes. 61
30633435 2019
166
Surgical treatment of early tongue squamous cell carcinoma and patient survival. 61
31186792 2019
167
Nomograms to predict survival of stage IV tongue squamous cell carcinoma after surgery. 61
31261568 2019
168
Molecular profile of tongue cancer in an 18-year-old female patient with no recognizable risk factor. 61
31236464 2019
169
Prognostic factors, failure patterns and survival analysis in patients with resectable oral squamous cell carcinoma of the tongue. 61
31266288 2019
170
Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden. 61
30584688 2019
171
World Workshop on Oral Medicine VII: Clinical evidence of differential expression of lncRNAs in oral squamous cell carcinoma: A scoping review. 61
31140697 2019
172
Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing. 61
30885939 2019
173
Hsa_circ_0001742 promotes tongue squamous cell carcinoma progression via modulating miR-634 expression. 61
30944081 2019
174
Clinical Implications of Tumor-Associated Tissue Eosinophilia in Tongue Squamous Cell Carcinoma. 61
30098046 2019
175
FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma. 61
31043585 2019
176
A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding. 61
30829728 2019
177
Prognostic performance of the American Joint Committee on Cancer 8th edition of the TNM staging system in patients with early oral tongue cancer. 61
30537405 2019
178
Oral tongue cancer in a patient with hereditary nonpolyposis colorectal cancer: A case report and review of the literature. 61
30885722 2019
179
lncRNA RP5-916L7.2 correlates with advanced tumor stage, and promotes cells proliferation while inhibits cells apoptosis through targeting miR-328 and miR-939 in tongue squamous cell carcinoma. 61
30825424 2019
180
Interleukin-17F Has Anti-Tumor Effects in Oral Tongue Cancer. 61
31083515 2019
181
Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth. 61
31011147 2019
182
Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling. 61
30995931 2019
183
Carotid Artery Involvement in Advanced Recurrent Head and Neck Cancer: A Case Report and Literature Review. 61
30500657 2019
184
[Effects of silencing Rce1 in vitro on the invasion and migration of tongue carcinoma]. 61
31168979 2019
185
LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis. 61
30970517 2019
186
Correction: Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma Progression. 61
30988097 2019
187
A novel prognostic model for tongue squamous cell carcinoma based on the characteristics of tumour and its microenvironment: iBD score. 61
30444275 2019
188
Analysis of Medical Error Contributing to Missed Acute Myeloid Leukemia Diagnosis. 61
31205835 2019
189
Human β-Defensin 2 Expression in Oral Epithelium: Potential Therapeutic Targets in Oral Lichen Planus. 61
30974892 2019
190
Numb inhibits epithelial-mesenchymal transition via RBP-Jκ-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer. 61
31023264 2019
191
Utility of intraoral ultrasound in managing oral tongue squamous cell carcinoma: Systematic review. 61
30151976 2019
192
MicroRNA‑758 inhibits tumorous behavior in tongue squamous cell carcinoma by directly targeting metadherin. 61
30628702 2019
193
Wnt7a predicts poor prognosis, and contributes to growth and metastasis in tongue squamous cell carcinoma. 61
30747225 2019
194
Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma. 61
30866854 2019
195
Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39]. 61
30529035 2019
196
[Effect of brazilin on apoptosis and autophagy of tongue cancer Tca8113 cells and its molecular mechanism]. 61
31068315 2019
197
Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early-stage tongue squamous cell carcinoma. 61
30548537 2019
198
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing. 61
30269358 2019
199
A pilot study of modified resection for anterior floor of the mouth squamous cell carcinoma without infiltration of the mandible. 61
30638742 2019
200
Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription. 61
30659020 2019
201
Matrix metalloproteinase 9 inhibits the motility of highly aggressive HSC-3 oral squamous cell carcinoma cells. 61
30710501 2019
202
TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence. 61
30794027 2019
203
Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma. 61
30565803 2019
204
[Effects of salinomycin on proliferative, migratory and invasive property of tongue squamous cell carcinoma cells in vitro]. 61
31080994 2019
205
A Multicenter Retrospective Study of Elective Neck Dissection for T1-2N0M0 Tongue Squamous Cell Carcinoma: Analysis Using Propensity Score-Matching. 61
30515671 2019
206
Evaluation of Liquid Based Cytology for Tongue Squamous Cell Carcinoma: Comparison with Conventional Cytology. 61
30700642 2019
207
H19 Facilitates Tongue Squamous Cell Carcinoma Migration and Invasion via Sponging miR-let-7. 61
29523225 2019
208
CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma. 61
30554431 2019
209
Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics. 61
30535462 2019
210
Integrative analysis of gene expression profiles reveals distinct molecular characteristics in oral tongue squamous cell carcinoma. 61
30675303 2019
211
MTHFD1L-Mediated Redox Homeostasis Promotes Tumor Progression in Tongue Squamous Cell Carcinoma. 61
31867267 2019
212
CRNDE promotes cell tongue squamous cell carcinoma cell growth and invasion through suppressing miR-384. 61
30242873 2019
213
Mitochondrial DNA variations in tongue squamous cell carcinoma. 61
30588299 2019
214
lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway. 61
30863103 2019
215
Secondary Squamous Cell Carcinoma of the Tongue Complicated with Bronchiolitis Obliterans as a Manifestation of Graft-versus-Host Disease following Peripheral Blood Stem Cell Transplantation. 61
31885954 2019
216
microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA. 61
31417317 2019
217
FGF-2 and FGFR-1 might be independent prognostic factors in oral tongue squamous cell carcinoma. 61
30129658 2019
218
High expression of TMEM40 contributes to progressive features of tongue squamous cell carcinoma. 61
30320346 2019
219
Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma. 61
30755833 2019
220
microRNA-493 inhibits tongue squamous cell carcinoma oncogenicity via directly targeting HMGA2. 61
31695410 2019
221
Functional analysis of lncRNAs based on competitive endogenous RNA in tongue squamous cell carcinoma. 61
31179185 2019
222
FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma. 61
31595151 2019
223
The oncogenic potential of PRR11 gene in Tongue Squamous Cell Carcinoma cells. 61
31258760 2019
224
MicroRNA-532-3p Suppresses Malignant Behaviors of Tongue Squamous Cell Carcinoma via Regulating CCR7. 61
31555130 2019
225
LncRNA DANCR promotes the proliferation, migration, and invasion of tongue squamous cell carcinoma cells through miR-135a-5p/KLF8 axis. 61
31827393 2019
226
Cell cycle markers and apoptotic proteins in oral tongue squamous cell carcinoma in young and elderly patients. 61
31778473 2019
227
Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. 61
30537401 2019
228
SDF-1-loaded PLGA nanoparticles for the targeted photoacoustic imaging and photothermal therapy of metastatic lymph nodes in tongue squamous cell carcinoma. 61
30385376 2019
229
Relationship between the maximum standardized uptake value of fluoro-2-deoxyglucose-positron emission tomography/computed tomography and clinicopathological characteristics in tongue squamous cell carcinoma. 61
31436241 2019
230
TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma. 61
31141819 2019
231
miR-17-5p promotes proliferation and migration of CAL-27 human tongue squamous cell carcinoma cells involved in autophagy inhibition under hypoxia. 61
31934030 2019
232
Correction: TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma. 61
31220179 2019
233
LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression. 61
30657561 2019
234
FLI-06 Intercepts Notch Signaling And Suppresses The Proliferation And Self-renewal Of Tongue Cancer Cells. 61
31571917 2019
235
Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation. 61
31534516 2019
236
Omitting Elective Irradiation of the Contralateral Retropharyngeal Nodes in Oropharyngeal Squamous Cell Carcinoma Treated with Intensity-modulated Radiotherapy. 61
30868038 2019
237
Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment. 61
31244955 2019
238
Early onset oral tongue cancer in the United States: A literature review. 61
30527223 2018
239
Nox4 Overexpression as a Poor Prognostic Factor in Patients with Oral Tongue Squamous Cell Carcinoma Receiving Surgical Resection. 61
30513726 2018
240
Immunohistochemical analysis of lymphatic vessel density and mast cells in oral tongue squamous cell carcinoma. 61
30482715 2018
241
Unusual Multinucleated Giant Cell Reaction in a Tongue Squamous Cell Carcinoma: Histopathological and Immunohistochemical Features. 61
29427031 2018
242
Cumulative incidence of neck recurrence with increasing depth of invasion. 61
30527241 2018
243
Long noncoding RNA GIHCG enhanced tongue squamous cell carcinoma progression through regulating miR-429. 61
29953645 2018
244
Antitumor activity of the plant extract morin in tongue squamous cell carcinoma cells. 61
30132559 2018
245
Function preservation with trimodality therapy in locally advanced oral tongue squamous cell carcinoma. 61
32177696 2018
246
Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway. 61
30244004 2018
247
Papillary Thyroid Carcinoma Incidentally Found in Cervical Lymph Nodes During Neck Dissection for Patients With Tongue Squamous Cell Carcinoma: A 3-Case Report and Literature Review. 61
30107162 2018
248
Oropharyngeal Squamous Cell Carcinoma Metastasis to Distal Skeletal Muscle on FDG PET/CT. 61
30179912 2018
249
Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway. 61
30106116 2018
250
Ethnicity based variation in expression of E-cadherin in patients with squamous cell carcinoma of the oral tongue. 61
30405799 2018
251
Identification and characterization of a highly metastatic epithelial cancer cell line from rat tongue cancer. 61
30059808 2018
252
Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures. 61
30172250 2018
253
Nuclear metallothionein in oral squamous cell carcinoma: clinicopathological parameters and patient survival. 61
30328895 2018
254
Disseminated tuberculosis caused by Mycobacterium bovis presenting as a tongue base mass. 61
30323101 2018
255
Effects of ionizing radiation and HPSE1 inhibition on the invasion of oral tongue carcinoma cells on human extracellular matrices in vitro. 61
30086306 2018
256
The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. 61
30173945 2018
257
Data on the aquaporin gene expression differences among ρ0, clinically relevant radioresistant, and the parental cells of human cervical cancer and human tongue squamous cell carcinoma. 61
30175205 2018
258
Role of Imaging in Clinically Occult Isolated Intrathyroidal Metastasis from Squamous Cell Carcinoma of Tongue: An Unusual Case Series. 61
30386055 2018
259
The tumorigenic functions of NADPH oxidase 5 (NOX5) in oral tongue squamous cell carcinoma. 61
32177513 2018
260
EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma. 61
30300334 2018
261
Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma. 61
29761594 2018
262
Free flap reconstruction for early stage tongue squamous cell carcinoma: surgical margin and recurrence. 61
30676880 2018
263
Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma. 61
29675646 2018
264
Anaplastic transition within the cancer microenvironment in early-stage oral tongue squamous cell carcinoma is associated with local recurrence. 61
30085337 2018
265
Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer. 61
30039390 2018
266
Depth of invasion on pathological outcomes in clinical low-stage oral tongue cancer patients. 61
29750853 2018
267
HIF-1α restricts proliferation and apoptosis of Tca8113 cells through up regulation of Hippo signaling pathway under hypoxic conditions. 61
30402847 2018
268
A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma. 61
30131545 2018
269
Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si. 61
28905287 2018
270
Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma. 61
29080392 2018
271
Interaction of cancer cell-derived Foxp3 and tumor microenvironment in human tongue squamous cell carcinoma. 61
30040923 2018
272
Silencing of uPAR via RNA interference inhibits invasion and migration of oral tongue squamous cell carcinoma. 61
30128018 2018
273
Sox2 promotes tumor aggressiveness and epithelial‑mesenchymal transition in tongue squamous cell carcinoma. 61
29956740 2018
274
Fermented Lingonberry Juice Inhibits Oral Tongue Squamous Cell Carcinoma Invasion In Vitro Similarly to Curcumin. 61
30150430 2018
275
Reactive Oxygen Species-Responsive Nanoparticles Based on PEGlated Prodrug for Targeted Treatment of Oral Tongue Squamous Cell Carcinoma by Combining Photodynamic Therapy and Chemotherapy. 61
30106279 2018
276
[Effect of human trophoblast cell-surface antigen 2 gene expression by RNA interference on proliferation and apoptosis of tongue squamous cell carcinoma and its mechanism]. 61
30196628 2018
277
Treponema denticola chymotrypsin-like proteinase is present in early-stage mobile tongue squamous cell carcinoma and related to the clinicopathological features. 61
29747237 2018
278
Oral tongue carcinoma among young patients: An analysis of risk factors and survival. 61
30115478 2018
279
BRCA2 protects mammalian cells from heat shock. 61
28891354 2018
280
Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue? 61
30344127 2018
281
Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway. 61
29845251 2018
282
miR-184 promotes cell proliferation in tongue squamous cell carcinoma by targeting SOX7. 61
30008922 2018
283
Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma. 61
29751146 2018
284
Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma. 61
29607565 2018
285
Safflower polysaccharide inhibits the development of tongue squamous cell carcinoma. 61
30103745 2018
286
Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling. 61
29901121 2018
287
Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome. 61
30061236 2018
288
Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p. 61
29804249 2018
289
Gastro-omental free flap for reconstruction of tongue defects. 61
30098769 2018
290
Protein kinase D1 regulates hypoxic metabolism through HIF-1α and glycolytic enzymes incancer cells. 61
29901206 2018
291
Constitutive activation and overexpression of NF-κB/c-Rel in conjunction with p50 contribute to aggressive tongue tumorigenesis. 61
30250646 2018
292
Free tissue flaps in head and neck reconstruction: clinical application and analysis of 93 patients of a single institution. 61
28571928 2018
293
miR-409-3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX. 61
29928443 2018
294
miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma. 61
30041677 2018
295
Assessment of cellular and serum proteome from tongue squamous cell carcinoma patient lacking addictive proclivities for tobacco, betel nut, and alcohol: Case study. 61
29236289 2018
296
MicroRNA-155, -185 and -193b as biomarkers in human papillomavirus positive and negative tonsillar and base of tongue squamous cell carcinoma. 61
29909906 2018
297
Epidemiological and Histopathological Aspects of Tongue Squamous Cell Carcinomas-Retrospective Study. 61
30647940 2018
298
Effects of lidocaine and the inclusion complex with 2-hydroxypropyl-β-cyclodextrin on cell viability and proliferation of oral squamous cell carcinoma. 61
29633269 2018
299
LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. 61
29970910 2018
300
Bafilomycin A1 increases the sensitivity of tongue squamous cell carcinoma cells to cisplatin by inhibiting the lysosomal uptake of platinum ions but not autophagy. 61
29524554 2018
301
Chemotherapy-Induced Long Non-coding RNA 1 Promotes Metastasis and Chemo-Resistance of TSCC via the Wnt/β-Catenin Signaling Pathway. 61
29699939 2018
302
Prognostic impact of perineural invasion in early stage oral tongue squamous cell carcinoma: Results from a prospective randomized trial. 61
29937161 2018
303
Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma. 61
29681158 2018
304
Rescue of iCIKs transfer from PD-1/PD-L1 immune inhibition in patients with resectable tongue squamous cell carcinoma (TSCC). 61
29653410 2018
305
Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma. 61
29307623 2018
306
Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States. 61
29645080 2018
307
Fabrication of Tongue Extracellular Matrix and Reconstitution of Tongue Squamous Cell Carcinoma In Vitro. 61
29985345 2018
308
CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma. 61
29844819 2018
309
Tongue carcinoma in young adults: a review of the literature. 61
29984792 2018
310
Patterns of recurrence in oral tongue cancer with perineural invasion. 61
29522275 2018
311
Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. 61
29427291 2018
312
CBX3/HP1γ is upregulated in tongue squamous cell carcinoma and is associated with an unfavorable prognosis. 61
29731822 2018
313
CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma. 61
29720147 2018
314
LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2. 61
29315846 2018
315
Utilizing the nanosecond pulse technique to improve antigen intracellular delivery and presentation to treat tongue squamous cell carcinoma. 61
29680844 2018
316
Anticancer activity of chlorhexidine and cranberry extract: an in-vitro study. 61
29790310 2018
317
IRX5 promotes NF-κB signalling to increase proliferation, migration and invasion via OPN in tongue squamous cell carcinoma. 61
29761910 2018
318
A rapidly growing human papillomavirus-positive oral tongue squamous cell carcinoma in a 21-year old female: A case report. 61
29849799 2018
319
[A Case of Consciousness Disorder Induced by the Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Cisplatin and 5-Fluorouracil Chemotherapy in a Patient with Tongue Cancer]. 61
30026451 2018
320
CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma. 61
29462646 2018
321
miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells. 61
29130787 2018
322
Cavernous sinus involvement in human papillomavirus associated oropharyngeal squamous cell carcinoma: case report of an atypical site of distant metastasis. 61
29743120 2018
323
Up-regulation of INSR/IGF1R by C-myc promotes TSCC tumorigenesis and metastasis through the NF-κB pathway. 61
29518496 2018
324
A functional haplotype of NFKB1 influence susceptibility to oral cancer: a population-based and in vitro study. 61
29635862 2018
325
Human papillomavirus and survival of patients per histological subsite of tonsillar squamous cell carcinoma. 61
29573210 2018
326
The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouth. 61
29393297 2018
327
Preoperative ultrasonography for tumor thickness evaluation in guiding management in patients with early oral tongue squamous cell carcinoma. 61
30050234 2018
328
FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment. 61
29393475 2018
329
Case of late-onset, relapsing surgical site infection related to a venous coupler placed during free flap reconstruction for major head and neck cancer. 61
29328540 2018
330
Reply to 'Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis". 61
29449674 2018
331
Digital metastasis of tongue squamous cell carcinoma. 61
29892666 2018
332
C-reactive protein is associated with the development of tongue squamous cell carcinoma. 61
29385406 2018
333
Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis'. 61
29449675 2018
334
Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma. 61
29149494 2018
335
Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma. 61
29286143 2018
336
FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop. 61
29360662 2018
337
SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway. 61
29071717 2018
338
A worldwide comparison of the management of surgical treatment of advanced oral cancer. 61
29395993 2018
339
HSP27-Mediated Extracellular and Intracellular Signaling Pathways Synergistically Confer Chemoresistance in Squamous Cell Carcinoma of Tongue. 61
29246940 2018
340
Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway. 61
29509252 2018
341
Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies. 61
28766010 2018
342
[Neck lymphatic metastasis, surgical methods and prognosis in early tongue squamous cell carcinoma]. 61
29429223 2018
343
Adipose-derived stem cell conditioned medium attenuates cisplatin-triggered apoptosis in tongue squamous cell carcinoma. 61
29207154 2018
344
MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma. 61
29434944 2018
345
[Expression and clinical significance of proline-rich tyrosine kinase 2 and phospho-protein kinase B in tongue squamous cell carcinoma]. 61
29594992 2018
346
Three-dimensional reconstruction with serial whole-mount sections of oral tongue squamous cell carcinoma: A preliminary study. 61
28960470 2018
347
Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma. 61
29138797 2018
348
Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma. 61
29371635 2018
349
Genome-wide gene expression profiling of tongue squamous cell carcinoma by RNA-seq. 61
28357642 2018
350
Tongue Squamous Cell Carcinoma in a European Lynx (Lynx Lynx): Papillomavirus Infection and Histologic Analysis. 61
29301274 2018
351
Morphological features of tongue squamous cell carcinoma diagnosed in Dolj County population between 2012-2014. 61
29940622 2018
352
Feasibility of desorption electrospray ionization mass spectrometry for diagnosis of oral tongue squamous cell carcinoma. 61
29078250 2018
353
Association between epstein barr virus and tongue squamous cell carcinoma in iranian patients. 61
29103768 2018
354
An Unusual Case of Tertiary Syphilis Behaving Like Tongue Squamous Cell Carcinoma. 61
30622992 2018
355
Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway. 61
29310682 2018
356
Constituents of Propolis: Chrysin, Caffeic Acid, p-Coumaric Acid, and Ferulic Acid Induce PRODH/POX-Dependent Apoptosis in Human Tongue Squamous Cell Carcinoma Cell (CAL-27). 61
29681859 2018
357
Deregulation of Hexokinase II Is Associated with Glycolysis, Autophagy, and the Epithelial-Mesenchymal Transition in Tongue Squamous Cell Carcinoma under Hypoxia. 61
29682563 2018
358
A Prognostic Nomogram Incorporating Depth of Tumor Invasion to Predict Long-term Overall Survival for Tongue Squamous Cell Carcinoma With R0 Resection. 61
29937929 2018
359
Effects of Curcumin on Squamous Cell Carcinoma of Tongue: An In Vitro Study. 61
29651934 2018
360
Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation. 61
29156523 2018
361
Resveratrol Induces Mitochondrial Apoptosis and Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells. 61
29148840 2018
362
Knockdown of HOXA transcript at the distal tip suppresses the growth and invasion and induces apoptosis of oral tongue squamous carcinoma cells. 61
30519045 2018
363
MicroRNA-488 inhibits tongue squamous carcinoma cell invasion and EMT by directly targeting ATF3. 61
29946339 2018
364
Zinc oxide nanoparticles induce toxicity in CAL 27 oral cancer cell lines by activating PINK1/Parkin-mediated mitophagy. 61
29950828 2018
365
Gene expression profiles and protein‑protein interaction networks during tongue carcinogenesis in the tumor microenvironment. 61
29115421 2018
366
Metabolic Profile of Oral Squamous Carcinoma Cell Lines Relies on a Higher Demand of Lipid Metabolism in Metastatic Cells. 61
29456966 2018
367
A model to predict nodal metastasis in patients with oral squamous cell carcinoma. 61
30091996 2018
368
"Deep Extrinsic Muscle Involvement" Is a Fallacy in the American Joint Committee on Cancer's Seventh Edition of Tumor Staging of Oral Cavity Cancers. 61
28683301 2018
369
VEGF-C/Flt-4 axis in tumor cells contributes to the progression of oral squamous cell carcinoma via upregulating VEGF-C itself and contactin-1 in an autocrine manner. 61
30416855 2018
370
Potential factors influencing the development of oral tongue squamous cell carcinoma in young mature patients: Lingual position of the mandibular second molar and narrow tongue space. 61
29344172 2017
371
Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy. 61
29039110 2017
372
A worldwide comparison of the management of T1 and T2 anterior floor of the mouth and tongue squamous cell carcinoma - Extent of surgical resection and reconstructive measures. 61
29033209 2017
373
Grape seed proanthocyanidins inhibit the proliferation, migration and invasion of tongue squamous cell carcinoma cells through suppressing the protein kinase B/nuclear factor-κB signaling pathway. 61
29039443 2017
374
Predictive Significance of Tumor Depth and Budding for Late Lymph Node Metastases in Patients with Clinical N0 Early Oral Tongue Carcinoma. 61
28374102 2017
375
Identification of differentially expressed genes in oral squamous cell carcinoma TCA8113 cells. 61
29344135 2017
376
Proteomic analysis of serum deprivation in tongue squamous cell carcinoma. 61
29039553 2017
377
Analysis of the outcome of young age tongue squamous cell carcinoma. 61
29302590 2017
378
Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis. 61
29240723 2017
379
High glucose enhances the metastatic potential of tongue squamous cell carcinoma via the PKM2 pathway. 61
29340090 2017
380
Histamine H4 receptor signalling in tongue cancer and its potential role in oral carcinogenesis - a short report. 61
28653289 2017
381
MicroRNA‑509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor. 61
28944863 2017
382
Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway. 61
28946186 2017
383
Diagnostic value of sentinel lymph node biopsy for cT1/T2N0 tongue squamous cell carcinoma: a meta-analysis. 61
28900723 2017
384
An in vitro study of the long non-coding RNA TUG1 in tongue squamous cell carcinoma. 61
28597931 2017
385
Rapid occurrence of left ventricular thrombus associated with platinum-based chemotherapy plus cetuximab for the treatment of metastatic squamous cell carcinoma of the head and neck: A case report. 61
29181174 2017
386
CXC chemokine‑7 inhibits growth and migration of oral tongue squamous cell carcinoma cells, mediated by the epithelial‑mesenchymal transition signaling pathway. 61
28901471 2017
387
Evidence that circulating proteins are more promising than miRNAs for identification of patients with squamous cell carcinoma of the tongue. 61
29262574 2017
388
Genomic profile of oral squamous cell carcinomas with an adjacent leukoplakia or with an erythroleukoplakia that evolved after the treatment of primary tumor: A report of two cases. 61
28901451 2017
389
PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs. 61
28947422 2017
390
Assessment of relationship of ABO blood groups among tobacco induced oral cancer patients of Kanpur Population, Uttar Pradesh. 61
29161780 2017
391
Natriuretic peptide receptor A is related to the expression of vascular endothelial growth factors A and C, and is associated with the invasion potential of tongue squamous cell carcinoma. 61
28521969 2017
392
ELAS1 induces apoptotic death in adenocarcinoma DU145 and squamous-cell carcinoma SAS cancer cells, but not in normal KD cells. 61
29156763 2017
393
Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma. 61
28982840 2017
394
Transoral bisected resection for T1-2 oral tongue squamous cell carcinoma to secure adequate deep margin. 61
28939079 2017
395
Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma. 61
29156735 2017
396
The influence of marital status on survival in patients with oral tongue squamous cell carcinoma. 61
29137247 2017
397
Dysregulation of AKT1, a miR-138 target gene, is involved in the migration and invasion of tongue squamous cell carcinoma. 61
28122142 2017
398
Upregulation of proline rich 11 is an independent unfavorable prognostic factor for survival of tongue squamous cell carcinoma patients. 61
29085449 2017
399
Differences in Clinicopathological Characteristics and Prognosis Between Primary and Postirradiation Tongue Squamous Cell Carcinoma. 61
28351659 2017
400
Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients. 61
28602571 2017
401
Isobavachalcone inhibits the proliferation and invasion of tongue squamous cell carcinoma cells. 61
28928824 2017
402
Pyruvate kinase M2 deregulation enhances the metastatic potential of tongue squamous cell carcinoma. 61
28978113 2017
403
Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. 61
28751758 2017
404
Ambiguity of Whole Body PET CT Scans in Diagnosis of Co-existing Tuberculosis and Malignancy: Is Histopathological Confirmation Mandatory? 61
29019325 2017
405
The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma. 61
28772283 2017
406
Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered? 61
28577181 2017
407
Crosstalk between tongue carcinoma cells, extracellular vesicles, and immune cells in in vitro and in vivo models. 61
28947958 2017
408
Oleic acid induces apoptosis and autophagy in the treatment of Tongue Squamous cell carcinomas. 61
28900281 2017
409
Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation. 61
28977904 2017
410
PDGFRA mRNA is overexpressed in oral cancer patients as compared to normal subjects with a significant trend of overexpression among tobacco users. 61
28342264 2017
411
[Effect of macrophage inflammatory protein-1β on proliferation and apoptosis of human tongue squamous cell carcinoma CAL-27 cells in vitro]. 61
28801293 2017
412
Decellularized tongue tissue as an in vitro model for studying tongue cancer and tongue regeneration. 61
28600128 2017
413
Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma. 61
28811537 2017
414
DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma. 61
27925687 2017
415
Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. 61
28839168 2017
416
Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress. 61
28526807 2017
417
[Effect of plumbagin on epithelial-mesenchymal transition and underlying mechanisms in human tongue squamous cell carcinoma cells]. 61
29972906 2017
418
Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma. 61
28747140 2017
419
Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cells. 61
28955754 2017
420
Cardiac metastasis of tongue squamous cell carcinoma complicated by pulmonary embolism: A case report. 61
28700484 2017
421
Radiotherapy alone or combined with chemotherapy for base of tongue squamous cell carcinoma. 61
28233903 2017
422
Improved outcomes with oral tongue squamous cell carcinoma in Finland. 61
28481417 2017
423
Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study. 61
27737535 2017
424
Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice. 61
28683823 2017
425
Loss of PTEN Expression Is Associated With High MicroRNA 24 Level and Poor Prognosis in Patients With Tongue Squamous Cell Carcinoma. 61
28413152 2017
426
hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma. 61
28535002 2017
427
The importance of lymph node ratio for locoregional recurrence of squamous cell carcinoma of the tongue. 61
28529103 2017
428
Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: control of occult neck metastasis. 61
28434836 2017
429
Regional recurrence in early stage I-II oral tongue cancer: a single institutional study and review of the literature. 61
28361597 2017
430
Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition. 61
28559016 2017
431
MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4. 61
28319306 2017
432
Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. 61
28559012 2017
433
The effectiveness of elective neck dissection on early (stage I, II) squamous cell carcinoma of the oral tongue. 61
28770154 2017
434
Nicotine may promote tongue squamous cell carcinoma progression by activating the Wnt/β-catenin and Wnt/PCP signaling pathways. 61
28521453 2017
435
Mesenchymal stem cell-derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells. 61
28208216 2017
436
Nomograms to estimate long-term overall survival and tongue cancer-specific survival of patients with tongue squamous cell carcinoma. 61
28411370 2017
437
Evaluation of tongue squamous cell carcinoma resection margins using ex-vivo MR. 61
28130702 2017
438
p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells. 61
28447720 2017
439
miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer. 61
28350138 2017
440
Predicting Radiotherapy Necessity in Tongue Cancer Using Lymph Node Yield. 61
27821247 2017
441
MicroRNAs in human tongue squamous cell carcinoma: From pathogenesis to therapeutic implications. 61
28351566 2017
442
Elective neck dissection in unilateral carcinomas of the tongue: Unilateral versus bilateral approach. 61
28216228 2017
443
Stromal interaction molecule 1 regulates growth, cell cycle, and apoptosis of human tongue squamous carcinoma cells. 61
28108672 2017
444
HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma. 61
27809392 2017
445
Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma. 61
28314297 2017
446
Phosphorylated Epidermal Growth Factor Receptor Expression Is Associated With Clinicopathologic Parameters and Patient Survival in Mobile Tongue Squamous Cell Carcinoma. 61
27657462 2017
447
Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma. 61
28038473 2017
448
Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma. 61
28039470 2017
449
Effects of irradiation on human leukocyte antigen class I expression in human papillomavirus positive and negative base of tongue and mobile tongue squamous cell carcinoma cell lines. 61
28350079 2017
450
Basaloid Squamous Cell Carcinoma of Tongue: A Report with Emphasis on Immunohistochemistry. 61
28511524 2017
451
Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway. 61
27831944 2017
452
The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma. 61
28626254 2017
453
Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups. 61
28095396 2017
454
Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. 61
27696557 2017
455
MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway. 61
27353727 2017
456
TUC338 Overexpression Leads to Enhanced Proliferation and Reduced Apoptosis in Tongue Squamous Cell Carcinoma Cells In Vitro. 61
27637778 2017
457
MicroRNA-149 targets specificity protein 1 to suppress human tongue squamous cell carcinoma cell proliferation and motility. 61
28356969 2017
458
[Expression and significance of human Dachshund homolog 1 in tongue squamous cell carcinoma and tongue atypical hyperplasia]. 61
28474069 2017
459
Radiosensitization of oral tongue squamous cell carcinoma by nanosecond pulsed electric fields (nsPEFs). 61
27676191 2017
460
Retrospective observational study of occult cervical lymph-node metastasis in T1N0 tongue cancer. 61
28175327 2017
461
Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain. 61
28092646 2017
462
Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma. 61
27821487 2017
463
Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma. 61
28700659 2017
464
Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. 61
28367232 2017
465
MicroRNA and protein profiles in invasive versus non-invasive oral tongue squamous cell carcinoma cells in vitro. 61
27773646 2017
466
Tumor-Associated Macrophages in the Development of 4-Nitroquinoline-1-Oxide-Induced Tongue Squamous Cell Carcinoma in a Mouse Model. 61
28633143 2017
467
IncRNA H19 promotes tongue squamous cell carcinoma progression through β-catenin/GSK3β/EMT signaling via association with EZH2. 61
28804564 2017
468
Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins. 61
28570699 2017
469
PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma. 61
28547980 2017
470
Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma. 61
28228691 2017
471
miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma. 61
28096697 2017
472
Radiotherapy in early-stage tongue squamous cell carcinoma with minor adverse features. 61
27507221 2017
473
Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR‑375. 61
27878285 2017
474
[Expression of Oct4 and Sox2 and their clinical significance in tongue squamous cell carcinoma]. 61
28072991 2017
475
A 16-gene signature predicting prognosis of patients with oral tongue squamous cell carcinoma. 61
29158988 2017
476
The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma. 61
28243118 2017
477
No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue. 61
28926591 2017
478
Hexokinase 2 enhances the metastatic potential of tongue squamous cell carcinoma via the SOD2-H2O2 pathway. 61
27926482 2017
479
Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway. 61
28035060 2017
480
miR-590-5P inhibits the progression of tongue squamous cell carcinoma by targeting FasL. 61
31966552 2017
481
miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/β-Catenin Pathway in Tongue Squamous Cell Carcinoma. 61
28337453 2017
482
Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10. 61
28919775 2017
483
Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma. 61
27932243 2017
484
Expression and Localization of Cathepsins B, D, and G in Two Cancer Stem Cell Subpopulations in Moderately Differentiated Oral Tongue Squamous Cell Carcinoma. 61
28775982 2017
485
Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats. 61
28574023 2017
486
Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer. 61
28900608 2017
487
Detection of Glutathione in Oral Squamous Cell Carcinoma Cells With a Fluorescent Probe During the Course of Oxidative Stress and Apoptosis. 61
27637779 2017
488
MFAP5 and TNNC1: Potential markers for predicting occult cervical lymphatic metastasis and prognosis in early stage tongue cancer. 61
27713166 2017
489
The Prevalence of Human Papilloma Virus in Squamous Cell Carcinoma of Oral Tongue. 61
29515636 2017
490
Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014. 61
27888679 2017
491
Cervical level IIb metastases in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. 61
28979139 2017
492
[Clinical application of relaying anteromedial thigh perforator flap in resurfacing of donor defect after anterolateral thigh flap transfer]. 61
29798629 2017
493
Hypoxia-induced epithelial-mesenchymal transition is regulated by phosphorylation of GSK3-β via PI3 K/Akt signaling in oral squamous cell carcinoma. 61
27614812 2016
494
High relative density of lymphatic vessels predicts poor survival in tongue squamous cell carcinoma. 61
27328960 2016
495
Characterizing Genetic Transitions of Copy Number Alterations and Allelic Imbalances in Oral Tongue Carcinoma Metastasis. 61
27461516 2016
496
Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study. 61
27537425 2016
497
Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma. 61
27835592 2016
498
The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinoma. 61
27505034 2016
499
Correlation between clinical and MRI assessment of depth of invasion in oral tongue squamous cell carcinoma. 61
27876067 2016
500
Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma. 61
27614428 2016
501
The role of prophylactic neck dissection and tumor thickness evaluation for patients with cN0 tongue squamous cell carcinoma. 61
27149875 2016
502
FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma. 61
27666346 2016
503
A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways. 61
27644244 2016
504
Does securin expression have significance in prognostication of oral tongue cancer? A pilot study. 61
27091335 2016
505
Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway. 61
27560546 2016
506
Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells. 61
27561828 2016
507
Prognostic factors of recurrence and neck metastasis in oral carcinomas. 61
28083063 2016
508
Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities. 61
27098612 2016
509
miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin. 61
27698823 2016
510
Efficacy of Elective Neck Dissection in T1/T2N0M0 Oral Tongue Squamous Cell Carcinoma: A Population-Based Analysis. 61
27165672 2016
511
Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma express components of the renin-angiotensin system. 61
27371611 2016
512
Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells. 61
29441929 2016
513
miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line. 61
28281960 2016
514
Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma. 61
27582550 2016
515
[A retrospective analysis on occult neck lymphatic metastasis in early tongue cancer]. 61
27765109 2016
516
MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion. 61
27571935 2016
517
Development and validation of Raman spectroscopic classification models to discriminate tongue squamous cell carcinoma from non-tumorous tissue. 61
27531871 2016
518
A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes. 61
27288358 2016
519
Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition. 61
27613832 2016
520
Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers. 61
27640185 2016
521
Important prognostic significance of lymph node density in patients with node positive oral tongue cancer. 61
27261269 2016
522
Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma. 61
27602138 2016
523
PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. 61
27507215 2016
524
Elective Neck Dissection vs Observation in Early-Stage Squamous Cell Carcinoma of the Oral Tongue With No Clinically Apparent Lymph Node Metastasis in the Neck: A Systematic Review and Meta-analysis. 61
27442962 2016
525
Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma. 61
27356955 2016
526
MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma. 61
27561985 2016
527
miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7. 61
27350307 2016
528
TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma. 61
26764364 2016
529
The anterolateral thigh flap for soft tissue reconstruction in patients with tongue squamous cell carcinoma. 61
27514796 2016
530
Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma. 61
27095085 2016
531
Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. 61
27391340 2016
532
Macroscopic technique for the evaluation of oral tongue tumour thickness: a reliable intraoperative method. 61
27034158 2016
533
Anatomic Invasive Depth Predicts Delayed Cervical Lymph Node Metastasis of Tongue Squamous Cell Carcinoma. 61
27186852 2016
534
14-3-3ζ silencing retards tongue squamous cell carcinoma progression by inhibiting cell survival and migration. 61
27080223 2016
535
The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma. 61
26982018 2016
536
Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma. 61
26525607 2016
537
Base of tongue squamous cell carcinoma with infiltrative bone marrow carcinomatosis after definitive chemoradiation: A case report. 61
26040510 2016
538
Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma. 61
27473117 2016
539
Erratum to: Tongue squamous cell carcinoma producing both parathyroid hormone-related protein and granulocyte colony-stimulating factor: a case report and literature review. 61
27435214 2016
540
Neurovascular Invasion and Histological Grade Serve as the Risk Factors of Cervical Lymph Node Metastases in Early Tongue Squamous Cell Carcinoma. 61
25911199 2016
541
xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells. 61
27347143 2016
542
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer. 61
26797786 2016
543
Tongue squamous cell carcinoma producing both parathyroid hormone-related protein and granulocyte colony-stimulating factor: a case report and literature review. 61
27316348 2016
544
miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma. 61
26943814 2016
545
Karyopherin α2 induces apoptosis in tongue squamous cell carcinoma CAL-27 cells through the p53 pathway. 61
27109484 2016
546
Neoplastic extracellular matrix environment promotes cancer invasion in vitro. 61
27090016 2016
547
microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. 61
27208839 2016
548
Occult level IV metastases in clinically node-negative patients with oral tongue squamous cell carcinoma. 61
27095552 2016
549
Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma. 61
26667395 2016
550
Upregulation of PTEN suppresses invasion in Tca8113 tongue cancer cells through repression of epithelial-mesenchymal transition (EMT). 61
26649861 2016
551
Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas. 61
26426362 2016
552
Immunohistochemical expression of secreted frizzled receptor protein 1 in the invasive front of tongue squamous cell carcinoma. 61
26921060 2016
553
Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma. 61
26759260 2016
554
Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. 61
26650483 2016
555
Prognostic significance of lymph node density in squamous cell carcinoma of the tongue. 61
25917601 2016
556
ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma. 61
26468018 2016
557
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. 61
26459312 2016
558
Clinical significance of three-dimensional measurement of tumour thickness on magnetic resonance imaging in patients with oral tongue squamous cell carcinoma. 61
26108641 2016
559
Tumor Infiltration Depth as Predictor of Nodal Metastasis in Early Tongue Squamous Cell Carcinoma. 61
26454032 2016
560
Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway. 61
26799420 2016
561
Distribution and significance of interstitial fibrosis and stroma-infiltrating B cells in tongue squamous cell carcinoma. 61
26998116 2016
562
Primary Systemic Amyloidosis with Unusual Dermatological Manifestations: A Rare Case Report. 61
27057028 2016
563
Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue. 61
23909955 2016
564
[Expression of LRG-1 in clinical specimens and Tca8113 cell line of tongue carcinoma]. 61
27063152 2016
565
Epidemiologic characteristics of oral cancer: single-center analysis of 4097 patients from the Sun Yat-sen University Cancer Center. 61
26940066 2016
566
[Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior]. 61
26885901 2016
567
CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. 61
26631955 2016
568
Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS. 61
26883054 2016
569
Squamous cell carcinoma of oral tongue in young patients - A 10 years tertiary care experience. 61
26819159 2016
570
Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis. 61
26175310 2016
571
HPV Infection and Prognostic Factors of Tongue Squamous Cell Carcinoma in Different Ethnic Groups from Geographically Closed Cohort in Xinjiang, China. 61
27034835 2016
572
Angiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway. 61
26870214 2016
573
Histopathological Parameters predicting Occult Nodal Metastases in Tongue Carcinoma Cases: An Indian Perspective. 61
27084866 2016
574
Effects of human Dachshund homolog 1 on the proliferation, migration, and adhesion of squamous cell carcinoma of the tongue. 61
26577501 2016
575
p53 Expression Helps Identify High Risk Oral Tongue Pre- malignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases. 61
26838208 2016
576
Akt Signal Transduction Pathways and Nuclear Factor-kappa B (NF-κB) Transcription as a Molecular Target of Oral Tongue Squamous Cell Carcinoma (SP-C1) Using Papua's Anthill Plant ( Myrmecodia pendans ). 61
29023018 2016
577
AEG-1 activates Wnt/PCP signaling to promote metastasis in tongue squamous cell carcinoma. 61
26689985 2016
578
MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma. 61
26498914 2016
579
Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations. 61
27280700 2016
580
Proapoptotic Activity of Propolis and Their Components on Human Tongue Squamous Cell Carcinoma Cell Line (CAL-27). 61
27281369 2016
581
BCL-2 inhibition impairs mitochondrial function and targets oral tongue squamous cell carcinoma. 61
27722045 2016
582
Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway. 61
26818837 2016
583
Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas. 61
27433284 2016
584
The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma. 61
26522733 2015
585
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control. 61
26225798 2015
586
Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique. 61
26590333 2015
587
Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential. 61
26517090 2015
588
Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters. 61
26421862 2015
589
Tumor necrosis factor α induces myofibroblast differentiation in human tongue cancer and promotes invasiveness and angiogenesis via secretion of stromal cell-derived factor-1. 61
26454580 2015
590
Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. 61
26058875 2015
591
MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma. 61
26365986 2015
592
Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stability. 61
26302210 2015
593
Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma. 61
26449430 2015
594
Immunohistochemical Evaluation of Angiogenesis and Cell Proliferation in Tongue Squamous Cell Carcinoma. 61
27507996 2015
595
A 3 dimensional assessment of the depth of tumor invasion in microinvasive tongue squamous cell carcinoma--A case series analysis. 61
26449426 2015
596
Computerized tomography based tumor-thickness measurement is useful to predict postoperative pathological tumor thickness in oral tongue squamous cell carcinoma. 61
26573595 2015
597
Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. 61
24954188 2015
598
Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer. 61
26581505 2015
599
Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal. 61
26303640 2015
600
A new surgical strategy for treatment of tongue squamous cell carcinoma based on anatomic study with preliminary clinical evaluation. 61
26321124 2015
601
FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT). 61
26362179 2015
602
The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma. 61
25169079 2015
603
Immunohistochemical study of vascular endothelial growth factor-C/vascular endothelial growth factor receptor-3 expression in oral tongue squamous cell carcinoma: Correlation with the induction of lymphangiogenesis. 61
26622791 2015
604
Comparative study of sentinel lymph node biopsy in clinically N0 oral tongue squamous cell carcinoma: Long-term oncologic outcomes between validation and application phases. 61
26231920 2015
605
Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma. 61
26483189 2015
606
Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer. 61
26216169 2015
607
Down-Regulating Receptor Interacting Protein Kinase 1 (RIP1) Promotes Oxaliplatin-Induced Tca8113 Cell Apoptosis. 61
26460489 2015
608
Comparison of Efficacy of Carbon Dioxide (CO2) Laser with Cutting Diathermy in Surgical Excision of Early Carcinoma Tongue. 61
26454392 2015
609
Prognostic Significance of Serine-Phosphorylated STAT3 Expression in pT1-T2 Oral Tongue Carcinoma. 61
26330924 2015
610
Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue. 61
25338738 2015
611
Squamous cell carcinoma of the oral tongue: histopathological parameters associated with outcome. 61
26055524 2015
612
FHL1 inhibits the growth of tongue squamous cell carcinoma cells via G1/S cell cycle arrest. 61
26017856 2015
613
Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma. 61
26622668 2015
614
HMME combined with green light-emitting diode irradiation results in efficient apoptosis on human tongue squamous cell carcinoma. 61
26210547 2015
615
X-ray radiation promotes the metastatic potential of tongue squamous cell carcinoma cells via modulation of biomechanical and cytoskeletal properties. 61
25586002 2015
616
Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers. 61
25863229 2015
617
Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study. 61
25941114 2015
618
[Repair surgical defect of squamous cell carcinoma of tongue base with advanced patients]. 61
26647531 2015
619
Expression of BMI1 and ZEB1 in epithelial-mesenchymal transition of tongue squamous cell carcinoma. 61
26043676 2015
620
Dysregulation of zinc finger protein, X-linked (ZFX) impairs cell proliferation and induces apoptosis in human oral squamous cell carcinorma. 61
25916205 2015
621
hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2). 61
26032517 2015
622
A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer. 61
26025766 2015
623
Prevalence of oral squamous cell carcinoma of tongue in and around Davangere, Karnataka, India: A retrospective study over 13 years. 61
26538904 2015
624
Predicting the Prognosis of Oral Tongue Carcinoma Using a Simple Quantitative Measurement Based on Preoperative MR Imaging: Tumor Thickness versus Tumor Volume. 61
25836729 2015
625
Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. 61
26057450 2015
626
Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer. 61
25760063 2015
627
For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. 61
25838076 2015
628
FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma. 61
25573594 2015
629
Overexpression of transforming growth factor type III receptor restores TGF-β1 sensitivity in human tongue squamous cell carcinoma cells. 61
26205654 2015
630
miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1. 61
25843291 2015
631
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis. 61
25912308 2015
632
[Total Glossolaryngectomy of an Advanced Oropharyngeal and Tongue Squamous-Cell Carcinoma: A 29-Case Series Study]. 61
26336747 2015
633
Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide. 61
26236659 2015
634
Anatomic-histologic study of the floor of the mouth: the lingual lymph nodes. 61
25770836 2015
635
Prognostic significance of hyoid bone invasion in advanced base of tongue carcinoma treated by chemoradiation. 61
25641627 2015
636
Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients. 61
26042932 2015
637
Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax. 61
25962755 2015
638
[Interleukin-23 strengthens the anti-apoptotic and drug resistance of human tongue squamous cell carcinoma through the Wingless-related integration site/β-catenin pathway]. 61
26281251 2015
639
Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer. 61
26094024 2015
640
Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma. 61
25965165 2015
641
Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience. 61
25620682 2015
642
A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma. 61
25697063 2015
643
Serum Level of Interleukin-6 in Patients with Oral Tongue Squamous cell Carcinoma. 61
26082902 2015
644
Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2. 61
25048179 2015
645
The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. 61
25212455 2015
646
Genome-wide analysis of cancer cell-derived Foxp3 target genes in human tongue squamous cell carcinoma cells. 61
25779374 2015
647
Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. 61
25169851 2015
648
Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. 61
24677273 2015
649
miR-375 inhibits cell growth and correlates with clinical outcomes in tongue squamous cell carcinoma. 61
25633534 2015
650
Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma. 61
25963193 2015
651
Large-volume barium aspiration. 61
25829647 2015
652
Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcinoma cell by upregulating the DNA methylation states of the promoter region. 61
25960229 2015
653
Application value of MRI combined with positron emission tomography (PET)/CT in diagnosis and preoperative staging of tongue squamous cell carcinoma. 61
25753588 2015
654
Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma. 61
25762643 2015
655
SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells. 61
25578561 2015
656
Overexpression of interleukin-18 protein reduces viability and induces apoptosis of tongue squamous cell carcinoma cells by activation of glycogen synthase kinase-3β signaling. 61
25591548 2015
657
Alisertib (MLN8237), a selective Aurora-A kinase inhibitor, induces apoptosis in human tongue squamous cell carcinoma cell both in vitro and in vivo. 61
25366143 2015
658
Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling. 61
25378227 2015
659
MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma. 61
25888093 2015
660
Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue. 61
24676727 2015
661
Affect on survival per increase in each millimeter of tumor depth in tongue cancer. 61
25621264 2015
662
miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist. 61
25501015 2015
663
Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. 61
25421538 2015
664
miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism. 61
25483152 2015
665
A simple novel prognostic model for early stage oral tongue cancer. 61
25457829 2015
666
High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer. 61
25040359 2015
667
Reduced Expression of the Antigen Processing Machinery Components TAP2, LMP2, and LMP7 in Tonsillar and Base of Tongue Cancer and Implications for Clinical Outcome. 61
25749172 2015
668
Subcellular location and photodynamic therapeutic effect of chlorin e6 in the human tongue squamous cell cancer Tca8113 cell line. 61
25621023 2015
669
Comparison of quality-of-life in tongue cancer patients undergoing tongue reconstruction with lateral upper arm free flap and radial forearm free flap. 61
26064380 2015
670
Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue. 61
25454575 2015
671
Spectrum analysis of Chinese vowels formant in patients with tongue carcinoma underwent hemiglossectomy. 61
25932247 2015
672
Overexpression of ZFX and its involvement in squamous cell carcinoma of the tongue. 61
25355536 2015
673
Pro-Inflammatory Cytokine IL-1β Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma. 61
26176534 2015
674
Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113. 61
25333745 2015
675
Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. 61
25834400 2015
676
Adenovirus expressing IFN-λ (Ad/hIFN-λ) produced anti-tumor effects through inducing apoptosis in human tongue squamous cell carcinoma cell. 61
26550161 2015
677
Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells. 61
26491260 2015
678
Integrated analysis of oral tongue squamous cell carcinoma identifies key variants and pathways linked to risk habits, HPV, clinical parameters and tumor recurrence. 61
26834999 2015
679
PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma. 61
25422907 2015
680
The role of miR-21 in proliferation and invasion capacity of human tongue squamous cell carcinoma in vitro. 61
26191145 2015
681
Effect of HIF-1α on biological activation of human tongue squamous cell carcinoma SCC-15 cells in vitro. 61
25816356 2015
682
Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma. 61
25552924 2015
683
Cytokeratin 13, Cytokeratin 17, Ki-67 and p53 Expression in Upper Layers of Epithelial Dysplasia Surrounding Tongue Squamous Cell Carcinoma. 61
26657521 2015
684
Predictive role of Toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma. 61
25264223 2015
685
The effects of combination of gefitinib and cisplatin on tongue squamous cell carcinoma cell lines. 61
25879333 2015
686
Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma. 61
25915207 2015
687
TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma. 61
25391621 2015
688
Macrophages modulate migration and invasion of human tongue squamous cell carcinoma. 61
25811194 2015
689
[The expression and clinical significance of BATF2 in oral tongue squamous cell carcinoma]. 61
25779069 2015
690
Targeting miR-21 with AS-miR-21 suppresses aggressive growth of human tongue squamous cell carcinoma in vivo. 61
26191167 2015
691
A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue. 61
25656280 2015
692
High expression of EphB6 protein in tongue squamous cell carcinoma is associated with a poor outcome. 61
26617870 2015
693
Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma? 61
25466506 2015
694
18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers. 61
25340950 2015
695
Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study. 61
25633184 2015
696
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma. 61
24488688 2014
697
Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. 61
25286028 2014
698
Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. 61
24343426 2014
699
miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1. 61
25127200 2014
700
Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience. 61
25091179 2014
701
The clinical value of lymphatic vessel density, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 expression in patients with oral tongue squamous cell carcinoma. 61
25450269 2014
702
Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer. 61
24762230 2014
703
miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1. 61
25130698 2014
704
Comparison of ultracentrifugation and density gradient separation methods for isolating Tca8113 human tongue cancer cell line-derived exosomes. 61
25202395 2014
705
Stromal myofibroblasts in squamous cell carcinoma of the tongue in young patients - a multicenter collaborative study. 61
25240996 2014
706
Does HMGB1 predict occult neck lymph node metastasis in early tongue carcinoma? A case-control study of 26 patients. 61
25230256 2014
707
TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival. 61
23996811 2014
708
Signaling pathways activation profiles make better markers of cancer than expression of individual genes. 61
25415353 2014
709
[Correlation analysis of EphA7 expression with clinico-pathological parameters and prognosis in tongue squamous cell carcinoma]. 61
25543601 2014
710
Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines. 61
25096824 2014
711
Altered histone mark deposition and DNA methylation at homeobox genes in human oral squamous cell carcinoma. 61
24519855 2014
712
HIF-1α regulated tongue squamous cell carcinoma cell growth via regulating VEGF expression in a xenograft model. 61
25405167 2014
713
A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma. 61
24645915 2014
714
Complete occlusal rehabilitation of patient with radiation caries - a case report. 61
25386544 2014
715
Elective neck dissection versus observation in the management of early tongue carcinoma with clinically node-negative neck: a retrospective study of 229 cases. 61
24529348 2014
716
Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis. 61
24450601 2014
717
In vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma. 61
25232209 2014
718
Regulatory T-cell infiltration in tongue squamous cell carcinoma. 61
24921153 2014
719
Tumor thickness as a predictive factor of lymph node metastasis and disease recurrence in T1N0 and T2N0 squamous cell carcinoma of the oral tongue. 61
24906946 2014
720
Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer. 61
25001480 2014
721
Upregulated ROS production induced by the proteasome inhibitor MG-132 on XBP1 gene expression and cell apoptosis in Tca-8113 cells. 61
25092240 2014
722
Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. 61
24682903 2014
723
Preoperative evaluation of oral tongue squamous cell carcinoma with intraoral ultrasound and magnetic resonance imaging-comparison with histopathological tumour thickness and accuracy in guiding patient management. 61
24598430 2014
724
Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. 61
24583139 2014
725
TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. 61
24431303 2014
726
Apoptosis of human tongue squamous cell carcinoma cell (CAL-27) induced by Lactobacillus sp. A-2 metabolites. 61
25141199 2014
727
Apc-Mutant Kyoto Apc Delta (KAD) Rats Are Susceptible to 4-NQO-Induced Tongue Carcinogenesis. 61
25050571 2014
728
Resection for oral tongue squamous cell carcinoma: a paradigm shift from conventional wide resection towards compartmental resection. 61
24685261 2014
729
[Differential proteomics research on exosomes derived from tongue squamous cell carcinoma cells and normal mucosa cells]. 61
25033647 2014
730
Tongue squamous cell carcinoma as a possible distinct entity in patients under 40 years old. 61
24932296 2014
731
Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis. 61
24629698 2014
732
Selective apoptotic cell death effects of oral cancer cells treated with destruxin B. 61
24972848 2014
733
[Application of fluorescence probe marked by quantum dots to detect early submandibular lymph node metastasis in a nude mouse model]. 61
25033645 2014
734
RIPK4 is downregulated in poorly differentiated tongue cancer and is associated with migration/invasion and cisplatin-induced apoptosis. 61
24519546 2014
735
Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells. 61
24530397 2014
736
Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. 61
23696499 2014
737
Facelift approach for neck dissection in squamous cell carcinoma of the lateral border of the tongue: application of this novel aesthetic technique in head and neck oncologic surgery. 61
24699109 2014
738
α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. 61
24313357 2014
739
[Signal transducer and activator of transcription-3 inhibitor WP1066 affects human tongue squamous cell carcinoma proliferation and apoptosis in vitro and in vivo]. 61
25031007 2014
740
Comments on "Sentinel lymph node biopsy versus elective neck dissection in patients with cT1-2 N0 oral tongue squamous cell carcinoma". 61
24582509 2014
741
MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4. 61
24609942 2014
742
Response to "Sentinel lymph node biopsy versus elective neck dissection in patients with cT1-2N0 oral tongue squamous cell carcinoma". 61
24581750 2014
743
Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. 61
24887090 2014
744
Perineural invasion and expression of nerve growth factor can predict the progression and prognosis of oral tongue squamous cell carcinoma. 61
24822265 2014
745
Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. 61
24022400 2014
746
Truncation of inhibitor of growth family protein 5 effectively induces senescence, but not apoptosis in human tongue squamous cell carcinoma cell line. 61
24254310 2014
747
MicroRNA-21 promotes oral cancer invasion via the Wnt/β-catenin pathway by targeting DKK2. 61
23999978 2014
748
Preoperative plasma fibrinogen predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. 61
24183736 2014
749
Relation between the expression of mitotic centromere-associated kinesin and the progression of squamous cell carcinoma of the tongue. 61
24445227 2014
750
Eosinophil depletion protects mice from tongue squamous cell carcinoma induced by 4-nitroquinoline-1-oxide. 61
24105297 2014
751
Patterns of cervical lymph node metastases in oral tongue squamous cell carcinoma: implications for elective and therapeutic neck dissection. 61
24548727 2014
752
The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas. 61
24362464 2014
753
Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma. 61
24346284 2014
754
Sentinel lymph node biopsy versus elective neck dissection in patients with cT1-2N0 oral tongue squamous cell carcinoma. 61
24332157 2014
755
[Effect of hypoglycosylated E-cadherins on proliferation and invasiveness of tongue squamous cell carcinoma]. 61
24608604 2014
756
Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma. 61
24511049 2014
757
Silencing Dicer expression enhances cellular proliferative and invasive capacities in human tongue squamous cell carcinoma. 61
24317682 2014
758
[Study of the biological characteristics of p75 neurotrophin receptor positive tongue squamous cell carcinoma cells]. 61
24665634 2014
759
Rapid detection of oral cancer using Ag-TiO2 nanostructured surface-enhanced Raman spectroscopic substrates. 61
32261617 2014
760
Tongue squamous cell carcinoma in young nonsmoking and nondrinking patients: 3 clinical cases of orthodontic interest. 61
24373660 2014
761
Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma. 61
24252932 2014
762
Oral tongue squamous cell carcinoma in young women: a matched comparison-do outcomes justify treatment intensity? 61
24734200 2014
763
RECQL1 plays an important role in the development of tongue squamous cell carcinoma. 61
24854846 2014
764
miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14. 61
25268950 2014
765
The immunohistochemical investigations of cadherin "switch" during epithelial-mesenchymal transition of tongue squamous cell carcinoma. 61
25607384 2014
766
Prediction of lymph node metastasis in T1/T2 tongue squamous cell carcinoma. 61
25675662 2014
767
Long non-coding RNA deregulation in tongue squamous cell carcinoma. 61
25045670 2014
768
Severe Pulmonary Suppuration with Infection-Induced Systemic Inflammatory Response Syndrome following Tongue Cancer Surgery in a Patient Undergoing Tocilizumab Therapy for Rheumatoid Arthritis. 61
24872899 2014
769
Neutrophils infiltration in the tongue squamous cell carcinoma and its correlation with CEACAM1 expression on tumor cells. 61
24587171 2014
770
Patterns of cancer cell sphere formation in primary cultures of human oral tongue squamous cell carcinoma and neck nodes. 61
25685059 2014
771
Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. 61
24332332 2014
772
P53 nuclear stabilization is associated with FHIT loss and younger age of onset in squamous cell carcinoma of oral tongue. 61
25152695 2014
773
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis. 61
24587339 2014
774
Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1. 61
25197261 2014
775
Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. 61
25339028 2014
776
Applicability of preoperative nuclear morphometry to evaluating risk for cervical lymph node metastasis in oral squamous cell carcinoma. 61
25549090 2014
777
Bcl-xL overexpression and its association with the progress of tongue carcinoma. 61
25550772 2014
778
Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma. 61
24999732 2014
779
Correlation of LMP10 expression and clinical outcome in Human Papillomavirus (HPV) positive and HPV-Negative tonsillar and base of tongue cancer. 61
24752327 2014
780
Evaluation of superficial oral squamous cell malignancy based on morphometry and immunoexpression of cytokeratin 13 and cytokeratin 17. 61
24247036 2014
781
Evaluation of swallow function after tongue cancer treatment using real-time magnetic resonance imaging: a pilot study. 61
24177574 2013
782
Quality of life in patients younger than 40 years treated for anterior tongue squamous cell carcinoma. 61
24220465 2013
783
Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis. 61
23551691 2013
784
Unexpected development of tongue squamous cell carcinoma after sclerotherapy for the venous malformation: a unique case report and literature review. 61
24188408 2013
785
miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma. 61
24148247 2013
786
Automatic upstaging of tongue squamous cell carcinoma with lateral extrinsic muscle involvement is not justified. 61
23849786 2013
787
Radiation induced sarcoma of oral cavity-a rare case report and a short review. 61
24392416 2013
788
One patient--three head and neck primaries: nasopharyngeal, tongue and thyroid cancers. 61
24164964 2013
789
Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years. 61
23927849 2013
790
AFM nanoindentation detection of the elastic modulus of tongue squamous carcinoma cells with different metastatic potentials. 61
23579203 2013
791
Predictors of locoregional recurrence in T1-2N0 tongue cancer patients. 61
23677778 2013
792
Dinuclear and heptanuclear complexes of copper(II) with 7-azaindole ligand: synthesis, characterization, magnetic properties, and biological activity. 61
23692703 2013
793
[Signal transducers and activators of transcription-3 modulates human squamous cell carcinoma invasion via targeting mircoRNA-21 in vitro]. 61
24314280 2013
794
MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113. 61
23827155 2013
795
Decrease of autophagy activity promotes malignant progression of tongue squamous cell carcinoma. 61
23464740 2013
796
Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival. 61
23533221 2013
797
Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway. 61
23519607 2013
798
Stable gene-silence of Kif2a synergistic with 5-fluorouracil suppresses oral tongue squamous cell carcinoma growth in vitro and in vivo. 61
23570661 2013
799
CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. 61
23571147 2013
800
Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ. 61
23687381 2013
801
Proteomic analysis of protein expression profiles during hyperthermia-induced apoptosis in Tca8113 cells. 61
23946791 2013
802
[The expression and significance of the Notch signaling pathway molecules in tongue squamous cell carcinoma]. 61
23841307 2013
803
Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome. 61
23434054 2013
804
Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma. 61
23446731 2013
805
Tongue reconstruction with tongue base island advancement flap. 61
23714931 2013
806
Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia. 61
23227892 2013
807
"You reap what you sow"--a case of heterotopic ossification within a fasciocutaneous radial forearm free flap reconstruction. 61
23433474 2013
808
Knockdown of Cdc6 inhibits proliferation of tongue squamous cell carcinoma Tca8113 cells. 61
22974333 2013
809
Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo. 61
23157415 2013
810
[Vasculogenic mimicry in tongue squamous cell carcinoma]. 61
23644128 2013
811
Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. 61
22161744 2013
812
Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. 61
22747515 2013
813
Decreased adiponectin level is associated with aggressive phenotype of tongue squamous cell carcinoma. 61
23181352 2013
814
Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. 61
23287987 2013
815
[Sonic hedgehog signaling enhanced the expression of histone demethylase, lysine-specific demethylase 8 in the head and neck squamous cell carcinoma cell line SCC-6]. 61
23714058 2013
816
Hypoxia-inducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma. 61
23251251 2013
817
Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma. 61
23357878 2013
818
Prognostic implications of micoRNA miR-195 expression in human tongue squamous cell carcinoma. 61
23451060 2013
819
Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro. 61
23951042 2013
820
Survivin gene polymorphism association with tongue squamous cell carcinoma. 61
23176035 2013
821
Three-dimensional reconstruction of oral tongue squamous cell carcinoma at invasion front. 61
24228031 2013
822
Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. 61
24278338 2013
823
Single nucleotide polymorphisms in the u-PA gene are related to susceptibility to oral tongue squamous cell carcinoma in the Northern Chinese Han population. 61
23621237 2013
824
Early stage oral tongue cancer among non-tobacco users--an increasing trend observed in a South Indian patient population presenting at a single centre. 61
24175776 2013
825
Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion. 61
24260116 2013
826
Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion. 61
24204919 2013
827
Quantitative proteomic analysis of sphere-forming stem-like oral cancer cells. 61
24423398 2013
828
Perineural tumor spread - Interconnection between spinal and cranial nerves. 61
23010545 2012
829
Oral cancer-associated fibroblasts inhibit heat-induced apoptosis in Tca8113 cells through upregulated expression of Bcl-2 through the Mig/CXCR3 axis. 61
22961626 2012
830
[In vivo study on antisense-micro ribonucleic acid-21 oligonucleotide inhibiting tongue squamous cell carcinoma growth]. 61
23330361 2012
831
[Overexpression of Twist1 promotes tumor invasion in human tongue squamous cell carcinoma cell line Tca8113]. 61
23232513 2012
832
Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma. 61
23118574 2012
833
Expression of semaphorin 3A and neuropilin 1 with clinicopathological features and survival in human tongue cancer. 61
22926477 2012
834
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP. 61
22909050 2012
835
The prognostic importance of midline involvement in oral tongue cancer. 61
21701377 2012
836
[Screen and analysis of differentially expressed genes related to stem-like cells in tongue squamous cell carcinoma Tca8113 cell line]. 61
23173306 2012
837
Blocking the Na+/H+ exchanger 1 with cariporide (HOE642) reduces the hypoxia-induced invasion of human tongue squamous cell carcinoma. 61
22464850 2012
838
The identification of significant chromosomal regions correlated with oral tongue cancer progression. 61
22638883 2012
839
FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. 61
22488171 2012
840
[Biological characteristics of cells expressing high level of aldehyde dehydrogenase subpopulation in tongue squamous cell carcinoma Tca8113 cell line]. 61
22934508 2012
841
Isolated skip nodal metastasis is rare in T1 and T2 oral tongue squamous cell carcinoma. 61
22371346 2012
842
[Biological effect of micro ribonucleic acid-21 on human tongue squamous cell carcinoma lines]. 61
22934486 2012
843
4-hexylresorcinol stimulates the differentiation of SCC-9 cells through the suppression of E2F2, E2F3 and Sp3 expression and the promotion of Sp1 expression. 61
22664654 2012
844
Elective neck dissection versus "wait and watch" policy in tongue carcinoma. 61
23066257 2012
845
Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma. 61
21953773 2012
846
IFNα2b augments immune responses of cisplatin+5-fluorouracil treated tongue squamous cell carcinoma patients--a preliminary study. 61
22885264 2012
847
Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. 61
22552321 2012
848
Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. 61
22580338 2012
849
A pioneering epidemiological study investigating the incidence of squamous cell carcinoma of tongue in a Portuguese population. 61
22322508 2012
850
Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma. 61
21647877 2012
851
Childhood tongue squamous cell carcinoma. 61
23626619 2012
852
Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. 61
22084953 2012
853
Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma. 61
22307065 2012
854
Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. 61
22320715 2012
855
Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma. 61
22023137 2012
856
The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. 61
21793937 2012
857
Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. 61
22153618 2012
858
Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study. 61
22253016 2012
859
Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy. 61
21913013 2012
860
Overexpression of interleukin-18 induces growth inhibition, apoptosis and gene expression changes in a human tongue squamous cell carcinoma cell line. 61
22613414 2012
861
Dysregulated CC receptor/ligand in monocytes/macrophages from tongue squamous cell carcinoma patients is partially rectified by interferon α-2b. 61
22085486 2012
862
Resistance/response molecular signature for oral tongue squamous cell carcinoma. 61
22297602 2012
863
Prognostic significance of invasion depth in oral tongue squamous cell carcinoma. 61
23128365 2012
864
2011 Young Surgeon's Award Winner: high endothelial venules: a novel prognostic marker in cancer metastasis and the missing link? 61
22499477 2012
865
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. 61
21725369 2012
866
[Study on neck management for tongue squamous cell carcinoma of cN0 stage]. 61
22332570 2011
867
Muscle invasion in oral tongue squamous cell carcinoma as a predictor of nodal status and local recurrence: just as effective as depth of invasion? 61
21892763 2011
868
Induction of apoptotic death by curcumin in human tongue squamous cell carcinoma SCC-4 cells is mediated through endoplasmic reticulum stress and mitochondria-dependent pathways. 61
21887696 2011
869
[Influence of epidermal growth factor receptor monoclony antibody MAb225 on DNA repair of tongue carcinoma cell after radiation]. 61
22332566 2011
870
Inhibition of 4-NQO-induced F433 rat tongue carcinogenesis by oleuropein-rich extract. 61
20596802 2011
871
IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma. 61
22067851 2011
872
TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma. 61
21821462 2011
873
Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. 61
21457345 2011
874
TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4. 61
21726607 2011
875
Andrographolide inhibits oral squamous cell carcinogenesis through NF-κB inactivation. 61
21841043 2011
876
Lentivirus-mediated gene silencing of beta-catenin inhibits growth of human tongue cancer cells. 61
21352379 2011
877
Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma. 61
21751148 2011
878
Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival. 61
22034891 2011
879
Apoptotic effect of MG-132 on human tongue squamous cell carcinoma. 61
21775096 2011
880
RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study. 61
21804460 2011
881
Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. 61
21481005 2011
882
Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. 61
21689966 2011
883
Use of laser phototherapy on a delayed wound healing of oral mucosa previously submitted to radiotherapy: case report. 61
21496209 2011
884
[Expression and significance of P75 neurotrophin receptor in oral squamous cell carcinoma]. 61
21909608 2011
885
Foxp3 expressed by tongue squamous cell carcinoma cells correlates with clinicopathologic features and overall survival in tongue squamous cell carcinoma patients. 61
21641272 2011
886
Correlation between E-cadherin and CD44 adhesion molecules expression and cervical lymph node metastasis in oral tongue SCC: Predictive significance or not. 61
21632186 2011
887
Free flap survival despite early loss of the vascular pedicle. 61
20175197 2011
888
Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue. 61
21726105 2011
889
Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. 61
21652258 2011
890
Histological and immunohistochemical evaluation of the chemopreventive role of lycopene in tongue carcinogenesis induced by 4-nitroquinoline-1-oxide. 61
21216390 2011
891
[Effects of N-cadherin expression on cell cycle, cell apoptosis and invasiveness and metastasis of tongue squamous cell carcinoma cell line Tca8113 cells]. 61
21914382 2011
892
High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study. 61
21707713 2011
893
[Expression of ERK and nm23-H1 in tongue squamous cell carcinoma and its relation with invasion and metastasis]. 61
21779735 2011
894
Synchronous squamous cell carcinoma of tongue and unicentric cervical Castleman's disease clinically mimicking a stage IV disease: a rare association or coincidence? 61
21240573 2011
895
Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. 61
20379753 2011
896
Management of base of tongue squamous cell carcinoma: experience with 85 patients in Taipei Veterans General Hospital. 61
21550009 2011
897
Cyclooxygenase-2 expression in oral tongue squamous cell carcinoma. 61
21481000 2011
898
[Vertical trapezius myocutaneous flap for repairing soft tissue defect after head and neck tumor resection]. 61
21675112 2011
899
Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. 61
21383286 2011
900
[Application of quantum dots fluorescent probes in tissue of human tongue squamous cell carcinoma]. 61
21598493 2011
901
Prophylactic neck dissection in early oral tongue squamous cell carcinoma 2.1 to 4.0 mm depth. 61
21493232 2011
902
Aesthetic and functional radical surgery in young patients with stage one or two tongue cancer: a preliminary report. 61
20417110 2011
903
Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. 61
21029181 2011
904
Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. 61
21079996 2011
905
Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. 61
21167768 2011
906
[Anti-sense miRNA-21 oligonucleotide inhibits Tb 3.1 human tongue squamous cell carcinoma growth in vitro]. 61
21426775 2011
907
Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. 61
20963646 2011
908
Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. 61
20390425 2011
909
[Anti-proliferative and anti-metastatic effects of curcumin on oral cancer cells]. 61
21427908 2011
910
Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry. 61
20969624 2011
911
Feasibility of preservation of the submandibular gland during neck dissection in patients with early-stage oral cancer. 61
20839068 2011
912
[Apoptosis induced by MG-132 in Tca-8113 cells]. 61
21451896 2011
913
Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line. 61
21293478 2011
914
Crocin inhibits proliferation and nucleic acid synthesis and induces apoptosis in the human tongue squamous cell carcinoma cell line Tca8113. 61
22320974 2011
915
Oral tongue squamous cell carcinoma (OTSCC): alcohol and tobacco consumption versus non-consumption. A study in a Portuguese population. 61
22189649 2011
916
Relationship between oral poor hygiene and broken teeth with oral tongue squamous cell carcinoma. 61
21681703 2011
917
Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors. 61
21167767 2011
918
Role of human papilloma virus in oral tongue squamous cell carcinoma. 61
21790221 2011
919
Phenotype of tumor lymphatic vessels is a prognostic factor in human tongue squamous cell carcinoma. 61
22870133 2011
920
Establishment and characterization of a rabbit oral squamous cell carcinoma cell line as a model for in vivo studies. 61
21071263 2011
921
Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. 61
21112238 2011
922
Activation of Notch signaling in human tongue carcinoma. 61
20819128 2011
923
Cervical lymph node metastases in squamous cell carcinoma of tongue and floor of mouth. 61
21276390 2011
924
Bazex syndrome (acrokeratosis paraneoplastica) diagnosed in a patient with oral persistent ulcerations. 61
20721648 2010
925
Correlation of β-catenin expresssion and metastasis in tongue squamous cell carcinoma. 61
21120283 2010
926
[Prognostic factors of early tongue squamous cell carcinoma and neck treatment]. 61
21215052 2010
927
[Effect of cyclooxygenase-2 inhibitor on expression of matrix metalloproteinase-2 and invasion of tongue squamous cell carcinoma cell line Tca8113]. 61
21365830 2010
928
MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. 61
20819078 2010
929
Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells. 61
21040473 2010
930
[Biological characteristics of CD133+ subpopulation in tongue squamous cell carcinoma Tca8113 cell line]. 61
21179699 2010
931
[Role of protein kinase C-delta in hyperthermia-induced apoptosis in tongue squamous cell carcinoma Tca8113 cells]. 61
21179694 2010
932
[Effects of RhoA siRNA on the proliferation, adhesion, migration and invasion of tongue squamous cell carcinoma Tca8113 cells in vitro]. 61
21122443 2010
933
MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. 61
20816961 2010
934
Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. 61
20340130 2010
935
Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). 61
20637681 2010
936
Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. 61
20232393 2010
937
Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma in vivo and in vitro. 61
20202090 2010
938
MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma. 61
20570137 2010
939
The SH3 domain, but not the catalytic domain, is required for phospholipase C-gamma1 to mediate epidermal growth factor-induced mitogenesis. 61
20621058 2010
940
Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome. 61
20738340 2010
941
Translocation (12;14) and other chromosome abnormalities in squamous cell carcinoma of the tongue. 61
20107997 2010
942
Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. 61
20054559 2010
943
Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma. 61
20618948 2010
944
[Effect of sodium phenylbutyrate on the apoptosis of human tongue squamous cancer cell line and expression of p21 and survivin genes]. 61
21122434 2010
945
Relationships of cervical lymph node metastasis to histopathological malignancy grade, tumor angiogenesis, and lymphatic invasion in tongue cancer. 61
20652794 2010
946
Squamous cell carcinoma of tongue in an 11-year-old girl. 61
20523246 2010
947
[Expression of NF-kappaB and COX-2 in tongue squamous cell carcinoma]. 61
20635052 2010
948
Prognostic value of LYVE-1-positive lymphatic vessel in tongue squamous cell carcinomas. 61
20651332 2010
949
Immunohistochemical study of β-catenin and functionally related molecular markers in tongue squamous cell carcinoma and its correlation with cellular proliferation. 61
22966322 2010
950
[Effect of peptide-conjugated quantum dots on the tumorigenicity and lymph node metastasis of human tongue squamous cell carcinoma cell line Tca8113 and mouse uterine cervix carcinoma U14 in vivo]. 61
20654248 2010
951
Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. 61
20504371 2010
952
[Expression of E-cadherin and beta-catenin in oral squamous cell carcinomas of tongue: correlation with the clinicopathologic features and patient prognosis]. 61
20654247 2010
953
Relative level of thymidylate synthase mRNA expression in primary tumors and normal tissues predicts survival of patients with oral tongue squamous cell carcinoma. 61
19697054 2010
954
Expression of caveolin-1 in tongue squamous cell carcinoma by quantum dots. 61
20558341 2010
955
MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. 61
20219416 2010
956
Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort. 61
20040528 2010
957
Altered phenotype of lymphatic endothelial cells induced by highly metastatic OTSCC cells contributed to the lymphatic metastasis of OTSCC cells. 61
20028389 2010
958
[Celecoxib induces cell cycle arrest and apoptosis in human tongue squamous carcinoma cell line Tca8113]. 61
20335116 2010
959
[Effect of microRNA on proliferation of human tongue carcinoma Tca8113 cells]. 61
20450682 2010
960
Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue. 61
19572285 2010
961
Expression of angiopoietin-like 4 and tenascin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma. 61
19775228 2010
962
[Study on the effects of overexpression of exogenous Notch1 in tongue squamous cell carcinoma cells on cell growth and expression of epidermal growth factor receptor in vitro]. 61
20337085 2010
963
Effect of local hyperthermia on lymphangiogenic factors VEGF-C and -D in a nude mouse xenograft model of tongue squamous cell carcinoma. 61
20036606 2010
964
[Role of NF-kappaB pathway in shikonin induced apoptosis in oral squamous cell carcinoma Tca-8113 cells]. 61
20300697 2010
965
Complete frozen section margins (with measurable 1 or 5 mm thick free margin) for cancer of the tongue: part 2: clinical experience. 61
20122340 2010
966
Survivin shRNA induces caspase-3-dependent apoptosis and enhances cisplatin sensitivity in squamous cell carcinoma of the tongue. 61
20441052 2010
967
Downregulation of Notch1 and its potential correlation with epidermal growth factor receptor signalling in tongue squamous cell carcinoma. 61
19398252 2010
968
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B. 61
20006625 2010
969
Hyperthermia-induced apoptosis in Tca8113 cells is inhibited by heat shock protein 27 through blocking phospholipid scramblase 3 phosphorylation. 61
20569108 2010
970
[Expression of Notch1 and epidermal growth factor receptor in human tongue squamous cell carcinoma and precancerous lesion]. 61
20077907 2009
971
[Cross-talk between Notch1 and epidermal growth factor receptor signalling in regulating cell proliferation of human tongue squamous carcinoma cells]. 61
20193370 2009
972
[Inhibitory effects of COX-2 inhibitor on migration of human tongue squamous cell carcinoma Tca8113 cells]. 61
19923064 2009
973
[Neck treatment strategy for pathologically node positive tongue squamous cell carcinoma.]. 61
20079074 2009
974
Expression of the FAM5C in tongue squamous cell carcinoma. 61
19787213 2009
975
Effect of peptide-conjugated near-infrared fluorescent quantum dots (NIRF-QDs) on the invasion and metastasis of human tongue squamous cell carcinoma cell line Tca8113 in vitro. 61
20057952 2009
976
Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function. 61
20505783 2009
977
PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. 61
19574087 2009
978
Squamous cell carcinoma of tongue in a renal transplant recipient. 61
20838555 2009
979
A novel organotypic model mimics the tumor microenvironment. 61
19679876 2009
980
Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma. 61
19559511 2009
981
Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma. 61